CN107475259B - 汉族人群家族性扩张型心肌病的筛查试剂盒 - Google Patents

汉族人群家族性扩张型心肌病的筛查试剂盒 Download PDF

Info

Publication number
CN107475259B
CN107475259B CN201710732660.2A CN201710732660A CN107475259B CN 107475259 B CN107475259 B CN 107475259B CN 201710732660 A CN201710732660 A CN 201710732660A CN 107475259 B CN107475259 B CN 107475259B
Authority
CN
China
Prior art keywords
glu
leu
lys
ala
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710732660.2A
Other languages
English (en)
Other versions
CN107475259A (zh
Inventor
舒先红
王小林
周年伟
秦胜梅
仇子龙
张翼
潘翠珍
赵维鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuyi Tianwen Shanghai Biotechnology Co ltd
Original Assignee
Zhongshan Hospital Fudan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan Hospital Fudan University filed Critical Zhongshan Hospital Fudan University
Priority to CN201710732660.2A priority Critical patent/CN107475259B/zh
Publication of CN107475259A publication Critical patent/CN107475259A/zh
Application granted granted Critical
Publication of CN107475259B publication Critical patent/CN107475259B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

本发明涉及汉族人群家族性扩张型心肌病的筛查试剂盒。本发明运用二代测序技术,通过外显子捕获富集全基因组DNA编码序列,发现了扩张型心肌病相关的致病基因及致病突变,包括:Chmp4c基因c.488A>G突变、LMNA基因c.961C>T突变和MYH7基因c.2458G>C突变,基于此提供了检测以上突变的扩张型心肌病筛查试剂盒。应用本发明的试剂盒能够提高扩张型心肌病患者早期检出率,有利于早期预防和治疗,提高患者生存率。

Description

汉族人群家族性扩张型心肌病的筛查试剂盒
技术领域
本发明涉及生物医学的疾病诊断技术领域,具体地说,涉及汉族人群家族性扩张型心肌病致病基因及突变位点的发现,和基于该致病基因及突变位点的扩张型心肌病筛查试剂盒。
背景技术
随着二代测序技术(Next-Generation Sequencing,NGS)的出现,特别是与外显子组捕获技术相结合的NGS能快速准确的了解基因序列信息,极大地帮助我们了解遗传性疾病,通过对家族相关基因的比对分析,能够较准确地发现致病基因及突变。
扩张型心肌病(Dilated Cardiomyopathy,DCM)是以左心室或双心室扩大,心室收缩功能障碍、心室壁变薄为主要特点的一种原发性心肌病,是导致心源性猝死和心力衰竭的主要原因。通过在患者家族中进行相关致病基因的研究发现,家族遗传所占的比例较高。家族性DCM的临床表型存在异质性,携带同一致病基因的家系不同成员之间的临床表现不尽相同,这可能与年龄,性别,基因突变的部位、类型等因素有关。根据以往研究报道统计,由于受限于检测技术以及对DCM整体认识水平,家族性DCM相关致病基因及突变检出率不到30%。经典的Sanger测序法准确性高,但检测序列的长度有限,效率较低,仅适用于筛选已知致病基因突变位点,很大程度上阻碍了DCM的致病基因检测。由于不同人种的遗传信息可能有差异,目前遗传分析中使用的数据欧美人群占很大的比例,汉族人群的数据较少,因此需要在汉族人群中近一步筛查研究。
专利文献CN1824776A,公开日2006.08.30,公开了目前已经有8个染色体定位与扩张型心肌病有关,并已确定了7个主要致病基因,包括:肌动蛋白(Actin)、肌营养不良蛋白(Dystrophy)、tafazzin、桥粒蛋白(Desmin)、δ-sarcoglycan、SCN5A和Lamin A/C,该发明还发现LMNA基因中G244A突变或者lamin A蛋白质中E82K突变会导致患者疾病如心脏疾病特别是扩张型心肌病的发生,基于此,提供了诊断患者疾病(如心脏疾病特别是扩张型心肌病)或者确定患者对疾病(如心脏疾病特别是扩张型心肌病)的遗传易感性的方法,所述方法包括检测来自所述患者的样品的LMNA基因中第244位G突变如G244A突变的存在或者lamin A蛋白质中第82位E突变如E82K突变的存在。专利文献CN103509867A,公开日2014.01.15,筛选出中国汉族人群最易感的4个散发性扩张型心肌病致病基因:MYBPC3、SCN5A、MYH7和MYPN,基于此开发出对中国汉族人群散发性扩张型心肌病有效的早期诊断方法和诊断试剂盒,有效提高扩张型心肌病患者早期检出率,从而做到早期治疗,提高患者生存率。
然而,发现新的致病基因及突变位点对于提高扩张型心肌病的筛查准确率来说仍然是十分必要的。
发明内容
本申请发明人运用二代测序技术发现了汉族人群家族性扩张型心肌病新的致病基因及突变位点,基于此完成了本发明。
第一方面,本发明提供一种分离的编码突变体的核酸分子或其片段,所述的核酸分子或其片段选自下列中的任一种:
d)与SEQ ID NO:1相比,具有c.488A>G突变;
e)与SEQ ID NO:7相比,具有c.961 C>T突变;
f)与SEQ ID NO:13相比,具有c.2458 G>C突变。
第二方面,本发明提供了一种分离的多肽或其片段,所述的多肽或其片段选自下列中的任一种:
d)与SEQ ID NO:2相比,具有p.Glu 163 Gly突变;
e)与SEQ ID NO:8相比,具有p.Arg 321 Ter突变;
f)与SEQ ID NO:14相比,具有p.Ala 820 Pro突变。
第三方面,本发明提供了一种用于筛查扩张型心肌病或筛选易患扩张型心肌病生物样品的试剂盒,含有:适于检测Chmp4c基因突变体、LMNA基因突变体或MYH7基因突变体的试剂,其中与SEQ ID NO:1相比,所述的Chmp4c基因突变体具有c.488A>G突变,与SEQ IDNO:7相比,所述的LMNA基因突变体具有c.961 C>T突变,与SEQ ID NO:13相比,所述的MYH7基因突变体具有c.2458G>C突变。
所述的扩张型心肌病为家族性扩张型心肌病。
所述的扩张型心肌病其患病个体属于汉族人群。
第四方面,本发明提供了一种筛查扩张型心肌病或筛选易患扩张型心肌病生物样品的系统,包括:
核酸提取装置,所述的核酸提取装置用于从所述的生物样品提取核酸样本;
核酸序列确定装置,所述的核酸序列确定装置与所述的核酸提取装置相连,用于对所述的核酸样本进行分析,以便确定所述的核酸样本的核酸序列;
判断装置,所述的判断装置与所述的核酸序列确定装置相连,以便基于所述核酸样本的核酸序列与SEQ ID NO:1相比,是否具有c.488A>G突变,或与SEQ ID NO:7相比,是否具有c.961 C>T突变,或与SEQ ID NO:13相比,是否具有c.2458G>C突变,判断所述的生物样品是否属于或易患扩张型心肌病。
作为一个具体例,所述的核酸提取装置进一步包括:RNA提取单元,所述的RNA提取单元用于从所述的生物样品提取RNA样本;以及反转录单元,所述的反转录单元与所述RNA提取单元相连,用于对所述的RNA样本进行反转录反应,以便获得cDNA样本,所述的cDNA样本构成所述的核酸样本。
作为一个具体例,所述的核酸序列确定装置进一步包括:文库构建单元,所述的文库构建单元用于针对所述核酸样本,构建核酸测序文库;以及测序单元,所述的测序单元与所述文库构建单元相连,用于对所述的核酸测序文库进行测序,以便获得由多个测序数据构成的测序结果。
第五方面,本发明提供了正常的Chmp4c基因或者正常的Chmp4c蛋白质在制备药物中的用途,所述的药物用于治疗或者预防扩张型心肌病,所述的患者具有Chmp4c基因c.488A>G突变或Chmp4c蛋白p.Glu 163 Gly突变。
第六方面,本发明提供了正常的LMNA基因或者正常的LMNA蛋白质在制备药物中的用途,所述的药物用于治疗或者预防扩张型心肌病,所述的患者具有LMNA基因c.961 C>T突变或LMNA蛋白p.Arg 321 Ter突变。
第七方面,本发明提供了正常的MYH7基因或者正常的MYH7蛋白质在制备药物中的用途,所述的药物用于治疗或者预防扩张型心肌病,所述的患者具有MYH7基因c.2458 G>C突变或MYH7蛋白p.Ala 820 Pro突变。
本文中,所述的“核酸分子”的类型不受特别限制,可以是任何包含与突变体的编码基因相对应的脱氧核糖核苷酸和/或核糖核苷酸的聚合物,包括但不限于DNA、RNA或cDNA。所述核酸,本领域技术人员应当理解,实际包括互补双链的任意一条,或者两条。为了方便,在本说明书和权利要求书中,虽然多数情况下只给出了一条链,但实际上也公开了与之互补的另一条链。例如,提及SEQ ID NO:1,实际包括其互补序列。本领域技术人员还可以理解,利用一条链可以检测另一条链,反之亦然。
所述的“生物样品”的类型并不受特别限制,只要从该生物样品中能够提取到反映生物样品是否存在突变的核酸样本即可。根据本发明的实施例,生物样品可以为选自人体血液、皮肤、皮下组织的至少一种,优选外周血。由此,可以方便地进行取样和检测,从而能够进一步提高筛选易患DCM的生物样品的效率。根据本发明的实施例,这里所使用的术语“核酸样本”应做广义理解,其可以是任何能够反映生物样品中是否存在突变的样本,例如可以是从生物样品中直接提取的全基因组DNA,也可以是该全基因组中包含致病基因编码序列的一部分,可以是从生物样品中提取的总RNA,也可以是从生物样品中提取的mRNA。
所述的“适于检测基因突变体的试剂”应做广义理解,即可以是检测病基因编码基因的试剂,也可以是检测突变体多肽的试剂,例如可以采用识别特异性位点的抗体。
本发明优点在于:
本发明运用二代测序技术,通过外显子捕获富集全基因组DNA编码序列,发现了扩张型心肌病相关的致病基因及致病突变,包括:Chmp4c基因c.488A>G突变、LMNA基因c.961C>T突变和MYH7基因c.2458 G>C突变,能够提高扩张型心肌病患者早期检出率,有利于早期预防和治疗,提高患者生存率。
附图说明
附图1是家系1的研究资料。
附图2是家系2的研究资料。
附图3是家系3的研究资料。
具体实施方式
下面结合附图对本发明提供的具体实施方式作详细说明。若未特别指明,实施例中所采用的技术手段为本领域技术人员所熟知的常规手段,可以参照《分子克隆实验指南》第3版或者相关产品进行,所采用的试剂和产品也均为可商业获得的。未详细描述的各种过程和方法是本领域中公知的常规方法,所用试剂的来源、商品名以及有必要列出其组成成分者,均在首次出现时标明,其后所用相同试剂如无特殊说明,均以首次标明的内容相同。
实施例1 Chmp4c(c.488A>G,p.Glu 163 Gly)
收集在我院就诊的DCM患者及其家系成员(家系1,图1)的临床资料,采集相关家系成员外周血并抽提DNA,对该家系成员行全基因组外显子测序,寻找致病基因,用Sanger测序对家系其他成员等进行验证。
1.一般临床资料收集:收集该家系所有成员详细的临床资料,包括体格检查,发病年龄,初发症状,血清肌酸激酶,纽约心功能分级,常规心电图,超声心动图,根据需要行动态心电图检查。所有研究对象签署知情同意书后,采集其外周血标本,按照试剂盒说明书步骤提取基因组DNA。本研究得到复旦大学附属中山医院伦理委员会的批准(2016-16B),所有研究对象都知情同意并签署知情同意书。
2.全外显子组测序:对家系成员的外周血DNA进行全外显子测序实验:样品核酸提取,超声打断,TruSeq DNA Sample Preparation试剂盒处理两端连接测序接头构建成文库,使用Roche Nimblegen SeqCap EZ v5.1试剂盒捕获全外显子区域,采用illumina XTEN平台进行高通量测序,数据质量Q30比例大于90%,外显子目标区域测序深度中位值>50×,95%目标区域测序深度>30×,外显子丢失率<0.2%。
3.测序数据分析:基因组测序原始数据经比对分析(bwamem/disco vardenovo/freebayes)取SNV及SV数据;CNV数据使用EulerCNV及CNVnator综合判断;SNV数据经inhouse cohort、dbSNP138及1000G_OMNI2.5注释携带率,使用snpEff及in house深度神经网络分析流程注释功能;剪切位点预测使用in house C++/R深度神经网络模型;CNV/SV数据经in house cohort、1000G及公开CNV数据库数据过滤携带率,使用Langya注释;信号转导通路分析使用in house R/Python/Perl package;OMIM/Monarch/ExAC数据库分析使用inhouse Perl/R API;表型基因型相关神经网络分析使用Langya/Marshes。数据解读参考美国医学遗传学和基因组学学院(American College of Medical Genetics and Genomics,ACMG)相关指南;变异命名参照HGVS建议的规则给出(http://www.hgvs.org/mutnomen/)。
结果:
由图1可知,该家系目前共有33个成员,DCM患者7名。其中,本家系先证者为一51岁女性患者(Ⅲ4),反复胸闷、晕厥来我院就诊。入院检查心电图提示房颤,三度房室传导阻滞,左束支传导阻滞;超声心动图提示全心增大伴左心室收缩功能减弱,左心室射血分数LVEF=34%,诊断为扩张型心肌病,接受了相关药物治疗并植入了起搏器。先证者的表哥(III7,III10)均诊断为扩张型心肌病,接受了相关药物治疗并植入了起搏器。先证者的表姐(III6)因扩张型心肌病去世。
收集上述DCM患者家系中患者及家系内正常人的外周血样本,经全外显子组测序和数据分析发现,先证者(Ⅲ4)和先证者表哥(III7,III10)的Chmp4c基因均存在c.488A>G,p.Glu 163 Gly的突变,成员(IV3,V3)为突变携带者,可能由于年龄原因暂时未表现出明显的扩张型心肌病临床症状,其他所有家系成员均不存在该突变。
野生型Chmp4c基因的CDS序列如SEQ ID NO:1所示,其编码的蛋白质的氨基酸序列如SEQ ID NO:2所示。Chmp4c基因突变体的CDS序列如SEQ ID NO:3所示,其编码的蛋白质的氨基酸序列如SEQ ID NO:4所示。
4.Sanger法测序验证:对该家系中患者及正常人,以及200名家系外正常人的Chmp4c基因进行检测:针对Chmp4c基因的c.488A>G突变设计引物,然后通过PCR扩增、产物纯化和测序的方法获得Chmp4c基因序列,确定序列测定结果属于突变型还是野生型,验证Chmp4c基因的c.488A>G突变与DCM之间的相关性。
突变引物序列为:
F:cgcccaagaaatctcagaag(SEQ ID NO:5);
R:ctgtgctgggagagaagagg(SEQ ID NO:6)。
结果表明,该家系中患者均携带Chmp4c基因的c.488A>G突变,而家系中正常人和200名家系外正常人均不携带该突变。
综上所述,证明Chmp4c基因的c.488A>G突变为DCM的致病突变。
实施例2 LMNA(c.961 C>T,p.Arg321Ter)
收集在我院就诊的DCM患者及其家系成员(家系2,图2)的临床资料,采集相关家系成员外周血并抽提DNA,对该家系成员行全基因组外显子测序,寻找致病基因,用Sanger测序对家系其他成员等进行验证。
1.一般临床资料收集:收集该家系所有成员详细的临床资料,包括体格检查,发病年龄,初发症状,血清肌酸激酶,纽约心功能分级,常规心电图,超声心动图,根据需要行动态心电图检查。所有研究对象签署知情同意书后,采集其外周血标本,按照试剂盒说明书步骤提取基因组DNA。本研究得到复旦大学附属中山医院伦理委员会的批准(2016-16B),所有研究对象都知情同意并签署知情同意书。
2.全外显子组测序:对家系成员的外周血DNA进行全外显子测序实验:样品核酸提取,超声打断,TruSeq DNA Sample Preparation试剂盒处理两端连接测序接头构建成文库,使用Roche Nimblegen SeqCap EZ v5.1试剂盒捕获全外显子区域,采用illumina XTEN平台进行高通量测序,数据质量Q30比例大于90%,外显子目标区域测序深度中位值>50×,95%目标区域测序深度>30×,外显子丢失率<0.2%。
3.测序数据分析:基因组测序原始数据经比对分析(bwamem/disco vardenovo/freebayes)取SNV及SV数据;CNV数据使用EulerCNV及CNVnator综合判断;SNV数据经inhouse cohort、dbSNP138及1000G_OMNI2.5注释携带率,使用snpEff及in house深度神经网络分析流程注释功能;剪切位点预测使用in house C++/R深度神经网络模型;CNV/SV数据经in house cohort、1000G及公开CNV数据库数据过滤携带率,使用Langya注释;信号转导通路分析使用in house R/Python/Perl package;OMIM/Monarch/ExAC数据库分析使用inhouse Perl/R API;表型基因型相关神经网络分析使用Langya/Marshes。数据解读参考美国医学遗传学和基因组学学院(American College of Medical Genetics and Genomics,ACMG)相关指南;变异命名参照HGVS建议的规则给出(http://www.hgvs.org/mutnomen/)。
结果:
由图1可知,该家系目前共有49个成员,DCM患者8名。其中,本家系先证者为一安徽籍43岁男性患者(Ⅲ7),反复心悸、晕厥来我院就诊,初步诊断为心律失常,房室传导阻滞。入院检查心电图提示房颤,三度房室传导阻滞,左束支传导阻滞;超声心动图提示左心房左心室增大伴左心室收缩功能减退,左心室射血分数LVEF=42%。该患者胸片提示心脏扩大;血肌酸激酶和肌钙蛋白T较正常值稍偏高,既往无高血压、冠心病及糖尿病病史,该患者诊断为扩张型心肌病,接受了相关药物治疗并植入了起搏器。先证者的表哥(III5),46岁,2年前被诊断为房颤,DCM,也接受了起搏器植入术。
收集上述DCM患者家系中患者及家系内正常人的外周血样本,经全外显子组测序和数据分析发现,先证者(Ⅲ7)和先证者表哥(III5)的LMNA基因均存在c.961 C>T,p.Arg321Ter的突变,成员(IV6,IV10)为突变携带者,可能由于年龄原因暂时未表现出明显的扩张型心肌病临床症状,其他所有家系成员均不存在该突变。
野生型LMNA基因的CDS序列如SEQ ID NO:7所示,其编码的蛋白质的氨基酸序列如SEQ ID NO:8所示。LMNA基因突变体的CDS序列如SEQ ID NO:9所示,其编码的蛋白质的氨基酸序列如SEQ ID NO:10所示。
4.Sanger法测序验证:对该家系中患者及正常人,以及200名家系外正常人的LMNA基因进行检测:针对LMNA基因的c.961 C>T突变设计引物,然后通过PCR扩增、产物纯化和测序的方法获得LMNA基因序列,确定序列测定结果属于突变型还是野生型,验证LMNA基因的c.961 C>T突变与DCM之间的相关性。
突变引物序列为:
F:cctctctgcccagctcag(SEQ ID NO:11);
R:gccagcttgatgtccagaag(SEQ ID NO:12)。
结果表明,该家系中患者均携带LMNA基因的c.961 C>T突变,而家系中正常人和200名家系外正常人均不携带该突变。
综上所述,证明LMNA基因的c.961 C>T突变为DCM的致病突变。
实施例3 MYH7(c.2458G>C,p.Ala820Pro)
收集在我院就诊的DCM患者及其家系成员(家系3,图3)的临床资料,采集相关家系成员外周血并抽提DNA,对该家系成员行全基因组外显子测序,寻找致病基因,用Sanger测序对家系其他成员等进行验证。
1.一般临床资料收集:收集该家系所有成员详细的临床资料,包括体格检查,发病年龄,初发症状,血清肌酸激酶,纽约心功能分级,常规心电图,超声心动图,根据需要行动态心电图检查。所有研究对象签署知情同意书后,采集其外周血标本,按照试剂盒说明书步骤提取基因组DNA。本研究得到复旦大学附属中山医院伦理委员会的批准(2016-16B),所有研究对象都知情同意并签署知情同意书。
2.全外显子组测序:对家系成员的外周血DNA进行全外显子测序实验:样品核酸提取,超声打断,TruSeq DNA Sample Preparation试剂盒处理两端连接测序接头构建成文库,使用Roche Nimblegen SeqCap EZ v5.1试剂盒捕获全外显子区域,采用illumina XTEN平台进行高通量测序,数据质量Q30比例大于90%,外显子目标区域测序深度中位值>50×,95%目标区域测序深度>30×,外显子丢失率<0.2%。
3.测序数据分析:基因组测序原始数据经比对分析(bwamem/disco vardenovo/freebayes)取SNV及SV数据;CNV数据使用EulerCNV及CNVnator综合判断;SNV数据经inhouse cohort、dbSNP138及1000G_OMNI2.5注释携带率,使用snpEff及in house深度神经网络分析流程注释功能;剪切位点预测使用in house C++/R深度神经网络模型;CNV/SV数据经in house cohort、1000G及公开CNV数据库数据过滤携带率,使用Langya注释;信号转导通路分析使用in house R/Python/Perl package;OMIM/Monarch/ExAC数据库分析使用inhouse Perl/R API;表型基因型相关神经网络分析使用Langya/Marshes。数据解读参考美国医学遗传学和基因组学学院(American College of Medical Genetics and Genomics,ACMG)相关指南;变异命名参照HGVS建议的规则给出(http://www.hgvs.org/mutnomen/)。
结果:
由图1可知,该家系目前共有8个成员,DCM患者3名。其中,本家系先证者为一42岁男性患者(II3),反复胸闷、胸痛来我院就诊。入院检查心电图提示房室传导阻滞;超声心动图提示左心增大伴左心室收缩功能减弱,左心室射血分数LVEF=41%,诊断为扩张型心肌病,接受了相关药物治疗并植入了起搏器。先证者的哥哥(II2)也为扩张型心肌病,接受相关药物治疗。先证者的父亲(I2)因心肌病去世。
收集上述DCM患者家系中患者及家系内正常人的外周血样本,经全外显子组测序和数据分析发现,先证者(II3)和先证者哥哥(II3)的MYH7基因均存在c.2458G>C,p.Ala820Pro的突变,其他所有家系成员均不存在该突变。
野生型MYH7基因的CDS序列如SEQ ID NO:13所示,其编码的蛋白质的氨基酸序列如SEQ ID NO:14所示。MYH7基因突变体的CDS序列如SEQ ID NO:15所示,其编码的蛋白质的氨基酸序列如SEQ ID NO:16所示。
4.Sanger法测序验证:对该家系中患者及正常人,以及200名家系外正常人的MYH7基因进行检测:针对MYH7基因的c.2458G>C突变设计引物,然后通过PCR扩增、产物纯化和测序的方法获得MYH7基因序列,确定序列测定结果属于突变型还是野生型,验证MYH7基因的c.2458G>C突变与DCM之间的相关性。
突变引物序列为:
F:gactccctgctggtaatcca(SEQ ID NO:17);
R:cctctttgaggcgtgtgaac(SEQ ID NO:18)。
结果表明,该家系中患者均携带MYH7基因的c.2458G>C突变,而家系中正常人和200名家系外正常人均不携带该突变。
综上所述,证明MYH7基因的c.2458G>C突变为DCM的致病突变。
实施例4筛查扩张型心肌病/易患扩张型心肌病生物样品的试剂盒
一种筛查扩张型心肌病/易患扩张型心肌病生物样品的试剂盒,其至少包含能够检测以下任一种突变的引物:Chmp4c基因的c.488A>G突变、LMNA基因的c.961 C>T突变、MYH7基因的c.2458 G>C突变,用于筛查易患扩张型心肌病的生物样品。优选地,用于检测Chmp4c基因的c.488A>G突变的引物系列如SEQ ID NO:5和SEQ ID NO:6所示,用于检测LMNA基因的c.961C>T突变的引物系列如SEQ ID NO:11和SEQ ID NO:12所示,用于检测MYH7基因的c.2458 G>C突变的引物系列如SEQ ID NO:17和SEQ ID NO:18所示。
利用上述试剂盒筛选患有或易患DCM的生物样品的具体步骤为:提取待测者DNA,以所提取的DNA为模板与上述引物进行PCR反应,并按照本领域常规方法对PCR产物纯化,将纯化的产物进行测序,然后通过观察测序所得到的序列是否具有对应突变,能够有效地检测本发明的Chmp4c、LMNA、MYH7基因突变体在待测者DNA中是否存在,从而能够有效地检测待测者是否易患DCM,进一步,能够从待测者中筛选出易患DCM的生物样品。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员,在不脱离本发明方法的前提下,还可以做出若干改进和补充,这些改进和补充也应视为本发明的保护范围。
SEQUENCE LISTING
<110> 复旦大学附属中山医院
<120> 汉族人群家族性扩张型心肌病的筛查试剂盒
<130> /
<160> 18
<170> PatentIn version 3.3
<210> 1
<211> 702
<212> DNA
<213> human
<400> 1
atgagcaagt tgggcaagtt ctttaaaggg ggcggctctt ctaagagccg agccgctccc 60
agtccccagg aggccctggt ccgacttcgg gagactgagg agatgctggg caagaaacaa 120
gagtacctgg aaaatcgaat ccagagagaa atcgccctgg ccaagaagca cggcacgcag 180
aataagcgag ctgcattaca ggcactaaag agaaagaaga ggttcgagaa acagctcact 240
cagattgatg gcacactttc taccattgag ttccagagag aagccctgga gaactcacac 300
accaacactg aggtgttgag gaacatgggc tttgcagcaa aagcgatgaa atctgttcat 360
gaaaacatgg atctgaacaa aatagatgat ttgatgcaag agatcacaga gcaacaggat 420
atcgcccaag aaatctcaga agcattttct caacgggttg gctttggtga tgactttgat 480
gaggatgagt tgatggcaga acttgaagaa ttggaacagg aggaattaaa taagaagatg 540
acaaatatcc gccttccaaa tgtgccttcc tcttctctcc cagcacagcc aaatagaaaa 600
ccaggcatgt cgtccactgc acgtcgatcc cgagcagcat cttcccagag ggcagaagaa 660
gaggatgatg atatcaaaca attggcagct tgggctacct aa 702
<210> 2
<211> 233
<212> PRT
<213> human
<400> 2
Met Ser Lys Leu Gly Lys Phe Phe Lys Gly Gly Gly Ser Ser Lys Ser
1 5 10 15
Arg Ala Ala Pro Ser Pro Gln Glu Ala Leu Val Arg Leu Arg Glu Thr
20 25 30
Glu Glu Met Leu Gly Lys Lys Gln Glu Tyr Leu Glu Asn Arg Ile Gln
35 40 45
Arg Glu Ile Ala Leu Ala Lys Lys His Gly Thr Gln Asn Lys Arg Ala
50 55 60
Ala Leu Gln Ala Leu Lys Arg Lys Lys Arg Phe Glu Lys Gln Leu Thr
65 70 75 80
Gln Ile Asp Gly Thr Leu Ser Thr Ile Glu Phe Gln Arg Glu Ala Leu
85 90 95
Glu Asn Ser His Thr Asn Thr Glu Val Leu Arg Asn Met Gly Phe Ala
100 105 110
Ala Lys Ala Met Lys Ser Val His Glu Asn Met Asp Leu Asn Lys Ile
115 120 125
Asp Asp Leu Met Gln Glu Ile Thr Glu Gln Gln Asp Ile Ala Gln Glu
130 135 140
Ile Ser Glu Ala Phe Ser Gln Arg Val Gly Phe Gly Asp Asp Phe Asp
145 150 155 160
Glu Asp Glu Leu Met Ala Glu Leu Glu Glu Leu Glu Gln Glu Glu Leu
165 170 175
Asn Lys Lys Met Thr Asn Ile Arg Leu Pro Asn Val Pro Ser Ser Ser
180 185 190
Leu Pro Ala Gln Pro Asn Arg Lys Pro Gly Met Ser Ser Thr Ala Arg
195 200 205
Arg Ser Arg Ala Ala Ser Ser Gln Arg Ala Glu Glu Glu Asp Asp Asp
210 215 220
Ile Lys Gln Leu Ala Ala Trp Ala Thr
225 230
<210> 3
<211> 702
<212> DNA
<213> human
<400> 3
atgagcaagt tgggcaagtt ctttaaaggg ggcggctctt ctaagagccg agccgctccc 60
agtccccagg aggccctggt ccgacttcgg gagactgagg agatgctggg caagaaacaa 120
gagtacctgg aaaatcgaat ccagagagaa atcgccctgg ccaagaagca cggcacgcag 180
aataagcgag ctgcattaca ggcactaaag agaaagaaga ggttcgagaa acagctcact 240
cagattgatg gcacactttc taccattgag ttccagagag aagccctgga gaactcacac 300
accaacactg aggtgttgag gaacatgggc tttgcagcaa aagcgatgaa atctgttcat 360
gaaaacatgg atctgaacaa aatagatgat ttgatgcaag agatcacaga gcaacaggat 420
atcgcccaag aaatctcaga agcattttct caacgggttg gctttggtga tgactttgat 480
gaggatgggt tgatggcaga acttgaagaa ttggaacagg aggaattaaa taagaagatg 540
acaaatatcc gccttccaaa tgtgccttcc tcttctctcc cagcacagcc aaatagaaaa 600
ccaggcatgt cgtccactgc acgtcgatcc cgagcagcat cttcccagag ggcagaagaa 660
gaggatgatg atatcaaaca attggcagct tgggctacct aa 702
<210> 4
<211> 233
<212> PRT
<213> human
<400> 4
Met Ser Lys Leu Gly Lys Phe Phe Lys Gly Gly Gly Ser Ser Lys Ser
1 5 10 15
Arg Ala Ala Pro Ser Pro Gln Glu Ala Leu Val Arg Leu Arg Glu Thr
20 25 30
Glu Glu Met Leu Gly Lys Lys Gln Glu Tyr Leu Glu Asn Arg Ile Gln
35 40 45
Arg Glu Ile Ala Leu Ala Lys Lys His Gly Thr Gln Asn Lys Arg Ala
50 55 60
Ala Leu Gln Ala Leu Lys Arg Lys Lys Arg Phe Glu Lys Gln Leu Thr
65 70 75 80
Gln Ile Asp Gly Thr Leu Ser Thr Ile Glu Phe Gln Arg Glu Ala Leu
85 90 95
Glu Asn Ser His Thr Asn Thr Glu Val Leu Arg Asn Met Gly Phe Ala
100 105 110
Ala Lys Ala Met Lys Ser Val His Glu Asn Met Asp Leu Asn Lys Ile
115 120 125
Asp Asp Leu Met Gln Glu Ile Thr Glu Gln Gln Asp Ile Ala Gln Glu
130 135 140
Ile Ser Glu Ala Phe Ser Gln Arg Val Gly Phe Gly Asp Asp Phe Asp
145 150 155 160
Glu Asp Gly Leu Met Ala Glu Leu Glu Glu Leu Glu Gln Glu Glu Leu
165 170 175
Asn Lys Lys Met Thr Asn Ile Arg Leu Pro Asn Val Pro Ser Ser Ser
180 185 190
Leu Pro Ala Gln Pro Asn Arg Lys Pro Gly Met Ser Ser Thr Ala Arg
195 200 205
Arg Ser Arg Ala Ala Ser Ser Gln Arg Ala Glu Glu Glu Asp Asp Asp
210 215 220
Ile Lys Gln Leu Ala Ala Trp Ala Thr
225 230
<210> 5
<211> 20
<212> DNA
<213> 人工序列
<400> 5
cgcccaagaa atctcagaag 20
<210> 6
<211> 20
<212> DNA
<213> 人工序列
<400> 6
ctgtgctggg agagaagagg 20
<210> 7
<211> 1995
<212> DNA
<213> human
<400> 7
atggagaccc cgtcccagcg gcgcgccacc cgcagcgggg cgcaggccag ctccactccg 60
ctgtcgccca cccgcatcac ccggctgcag gagaaggagg acctgcagga gctcaatgat 120
cgcttggcgg tctacatcga ccgtgtgcgc tcgctggaaa cggagaacgc agggctgcgc 180
cttcgcatca ccgagtctga agaggtggtc agccgcgagg tgtccggcat caaggccgcc 240
tacgaggccg agctcgggga tgcccgcaag acccttgact cagtagccaa ggagcgcgcc 300
cgcctgcagc tggagctgag caaagtgcgt gaggagttta aggagctgaa agcgcgcaat 360
accaagaagg agggtgacct gatagctgct caggctcggc tgaaggacct ggaggctctg 420
ctgaactcca aggaggccgc actgagcact gctctcagtg agaagcgcac gctggagggc 480
gagctgcatg atctgcgggg ccaggtggcc aagcttgagg cagccctagg tgaggccaag 540
aagcaacttc aggatgagat gctgcggcgg gtggatgctg agaacaggct gcagaccatg 600
aaggaggaac tggacttcca gaagaacatc tacagtgagg agctgcgtga gaccaagcgc 660
cgtcatgaga cccgactggt ggagattgac aatgggaagc agcgtgagtt tgagagccgg 720
ctggcggatg cgctgcagga actgcgggcc cagcatgagg accaggtgga gcagtataag 780
aaggagctgg agaagactta ttctgccaag ctggacaatg ccaggcagtc tgctgagagg 840
aacagcaacc tggtgggggc tgcccacgag gagctgcagc agtcgcgcat ccgcatcgac 900
agcctctctg cccagctcag ccagctccag aagcagctgg cagccaagga ggcgaagctt 960
cgagacctgg aggactcact ggcccgtgag cgggacacca gccggcggct gctggcggaa 1020
aaggagcggg agatggccga gatgcgggca aggatgcagc agcagctgga cgagtaccag 1080
gagcttctgg acatcaagct ggccctggac atggagatcc acgcctaccg caagctcttg 1140
gagggcgagg aggagaggct acgcctgtcc cccagcccta cctcgcagcg cagccgtggc 1200
cgtgcttcct ctcactcatc ccagacacag ggtgggggca gcgtcaccaa aaagcgcaaa 1260
ctggagtcca ctgagagccg cagcagcttc tcacagcacg cacgcactag cgggcgcgtg 1320
gccgtggagg aggtggatga ggagggcaag tttgtccggc tgcgcaacaa gtccaatgag 1380
gaccagtcca tgggcaattg gcagatcaag cgccagaatg gagatgatcc cttgctgact 1440
taccggttcc caccaaagtt caccctgaag gctgggcagg tggtgacgat ctgggctgca 1500
ggagctgggg ccacccacag cccccctacc gacctggtgt ggaaggcaca gaacacctgg 1560
ggctgcggga acagcctgcg tacggctctc atcaactcca ctggggaaga agtggccatg 1620
cgcaagctgg tgcgctcagt gactgtggtt gaggacgacg aggatgagga tggagatgac 1680
ctgctccatc accaccacgg ctcccactgc agcagctcgg gggaccccgc tgagtacaac 1740
ctgcgctcgc gcaccgtgct gtgcgggacc tgcgggcagc ctgccgacaa ggcatctgcc 1800
agcggctcag gagcccaggt gggcggaccc atctcctctg gctcttctgc ctccagtgtc 1860
acggtcactc gcagctaccg cagtgtgggg ggcagtgggg gtggcagctt cggggacaat 1920
ctggtcaccc gctcctacct cctgggcaac tccagccccc gaacccagag cccccagaac 1980
tgcagcatca tgtaa 1995
<210> 8
<211> 664
<212> PRT
<213> human
<400> 8
Met Glu Thr Pro Ser Gln Arg Arg Ala Thr Arg Ser Gly Ala Gln Ala
1 5 10 15
Ser Ser Thr Pro Leu Ser Pro Thr Arg Ile Thr Arg Leu Gln Glu Lys
20 25 30
Glu Asp Leu Gln Glu Leu Asn Asp Arg Leu Ala Val Tyr Ile Asp Arg
35 40 45
Val Arg Ser Leu Glu Thr Glu Asn Ala Gly Leu Arg Leu Arg Ile Thr
50 55 60
Glu Ser Glu Glu Val Val Ser Arg Glu Val Ser Gly Ile Lys Ala Ala
65 70 75 80
Tyr Glu Ala Glu Leu Gly Asp Ala Arg Lys Thr Leu Asp Ser Val Ala
85 90 95
Lys Glu Arg Ala Arg Leu Gln Leu Glu Leu Ser Lys Val Arg Glu Glu
100 105 110
Phe Lys Glu Leu Lys Ala Arg Asn Thr Lys Lys Glu Gly Asp Leu Ile
115 120 125
Ala Ala Gln Ala Arg Leu Lys Asp Leu Glu Ala Leu Leu Asn Ser Lys
130 135 140
Glu Ala Ala Leu Ser Thr Ala Leu Ser Glu Lys Arg Thr Leu Glu Gly
145 150 155 160
Glu Leu His Asp Leu Arg Gly Gln Val Ala Lys Leu Glu Ala Ala Leu
165 170 175
Gly Glu Ala Lys Lys Gln Leu Gln Asp Glu Met Leu Arg Arg Val Asp
180 185 190
Ala Glu Asn Arg Leu Gln Thr Met Lys Glu Glu Leu Asp Phe Gln Lys
195 200 205
Asn Ile Tyr Ser Glu Glu Leu Arg Glu Thr Lys Arg Arg His Glu Thr
210 215 220
Arg Leu Val Glu Ile Asp Asn Gly Lys Gln Arg Glu Phe Glu Ser Arg
225 230 235 240
Leu Ala Asp Ala Leu Gln Glu Leu Arg Ala Gln His Glu Asp Gln Val
245 250 255
Glu Gln Tyr Lys Lys Glu Leu Glu Lys Thr Tyr Ser Ala Lys Leu Asp
260 265 270
Asn Ala Arg Gln Ser Ala Glu Arg Asn Ser Asn Leu Val Gly Ala Ala
275 280 285
His Glu Glu Leu Gln Gln Ser Arg Ile Arg Ile Asp Ser Leu Ser Ala
290 295 300
Gln Leu Ser Gln Leu Gln Lys Gln Leu Ala Ala Lys Glu Ala Lys Leu
305 310 315 320
Arg Asp Leu Glu Asp Ser Leu Ala Arg Glu Arg Asp Thr Ser Arg Arg
325 330 335
Leu Leu Ala Glu Lys Glu Arg Glu Met Ala Glu Met Arg Ala Arg Met
340 345 350
Gln Gln Gln Leu Asp Glu Tyr Gln Glu Leu Leu Asp Ile Lys Leu Ala
355 360 365
Leu Asp Met Glu Ile His Ala Tyr Arg Lys Leu Leu Glu Gly Glu Glu
370 375 380
Glu Arg Leu Arg Leu Ser Pro Ser Pro Thr Ser Gln Arg Ser Arg Gly
385 390 395 400
Arg Ala Ser Ser His Ser Ser Gln Thr Gln Gly Gly Gly Ser Val Thr
405 410 415
Lys Lys Arg Lys Leu Glu Ser Thr Glu Ser Arg Ser Ser Phe Ser Gln
420 425 430
His Ala Arg Thr Ser Gly Arg Val Ala Val Glu Glu Val Asp Glu Glu
435 440 445
Gly Lys Phe Val Arg Leu Arg Asn Lys Ser Asn Glu Asp Gln Ser Met
450 455 460
Gly Asn Trp Gln Ile Lys Arg Gln Asn Gly Asp Asp Pro Leu Leu Thr
465 470 475 480
Tyr Arg Phe Pro Pro Lys Phe Thr Leu Lys Ala Gly Gln Val Val Thr
485 490 495
Ile Trp Ala Ala Gly Ala Gly Ala Thr His Ser Pro Pro Thr Asp Leu
500 505 510
Val Trp Lys Ala Gln Asn Thr Trp Gly Cys Gly Asn Ser Leu Arg Thr
515 520 525
Ala Leu Ile Asn Ser Thr Gly Glu Glu Val Ala Met Arg Lys Leu Val
530 535 540
Arg Ser Val Thr Val Val Glu Asp Asp Glu Asp Glu Asp Gly Asp Asp
545 550 555 560
Leu Leu His His His His Gly Ser His Cys Ser Ser Ser Gly Asp Pro
565 570 575
Ala Glu Tyr Asn Leu Arg Ser Arg Thr Val Leu Cys Gly Thr Cys Gly
580 585 590
Gln Pro Ala Asp Lys Ala Ser Ala Ser Gly Ser Gly Ala Gln Val Gly
595 600 605
Gly Pro Ile Ser Ser Gly Ser Ser Ala Ser Ser Val Thr Val Thr Arg
610 615 620
Ser Tyr Arg Ser Val Gly Gly Ser Gly Gly Gly Ser Phe Gly Asp Asn
625 630 635 640
Leu Val Thr Arg Ser Tyr Leu Leu Gly Asn Ser Ser Pro Arg Thr Gln
645 650 655
Ser Pro Gln Asn Cys Ser Ile Met
660
<210> 9
<211> 1995
<212> DNA
<213> human
<400> 9
atggagaccc cgtcccagcg gcgcgccacc cgcagcgggg cgcaggccag ctccactccg 60
ctgtcgccca cccgcatcac ccggctgcag gagaaggagg acctgcagga gctcaatgat 120
cgcttggcgg tctacatcga ccgtgtgcgc tcgctggaaa cggagaacgc agggctgcgc 180
cttcgcatca ccgagtctga agaggtggtc agccgcgagg tgtccggcat caaggccgcc 240
tacgaggccg agctcgggga tgcccgcaag acccttgact cagtagccaa ggagcgcgcc 300
cgcctgcagc tggagctgag caaagtgcgt gaggagttta aggagctgaa agcgcgcaat 360
accaagaagg agggtgacct gatagctgct caggctcggc tgaaggacct ggaggctctg 420
ctgaactcca aggaggccgc actgagcact gctctcagtg agaagcgcac gctggagggc 480
gagctgcatg atctgcgggg ccaggtggcc aagcttgagg cagccctagg tgaggccaag 540
aagcaacttc aggatgagat gctgcggcgg gtggatgctg agaacaggct gcagaccatg 600
aaggaggaac tggacttcca gaagaacatc tacagtgagg agctgcgtga gaccaagcgc 660
cgtcatgaga cccgactggt ggagattgac aatgggaagc agcgtgagtt tgagagccgg 720
ctggcggatg cgctgcagga actgcgggcc cagcatgagg accaggtgga gcagtataag 780
aaggagctgg agaagactta ttctgccaag ctggacaatg ccaggcagtc tgctgagagg 840
aacagcaacc tggtgggggc tgcccacgag gagctgcagc agtcgcgcat ccgcatcgac 900
agcctctctg cccagctcag ccagctccag aagcagctgg cagccaagga ggcgaagctt 960
tgagacctgg aggactcact ggcccgtgag cgggacacca gccggcggct gctggcggaa 1020
aaggagcggg agatggccga gatgcgggca aggatgcagc agcagctgga cgagtaccag 1080
gagcttctgg acatcaagct ggccctggac atggagatcc acgcctaccg caagctcttg 1140
gagggcgagg aggagaggct acgcctgtcc cccagcccta cctcgcagcg cagccgtggc 1200
cgtgcttcct ctcactcatc ccagacacag ggtgggggca gcgtcaccaa aaagcgcaaa 1260
ctggagtcca ctgagagccg cagcagcttc tcacagcacg cacgcactag cgggcgcgtg 1320
gccgtggagg aggtggatga ggagggcaag tttgtccggc tgcgcaacaa gtccaatgag 1380
gaccagtcca tgggcaattg gcagatcaag cgccagaatg gagatgatcc cttgctgact 1440
taccggttcc caccaaagtt caccctgaag gctgggcagg tggtgacgat ctgggctgca 1500
ggagctgggg ccacccacag cccccctacc gacctggtgt ggaaggcaca gaacacctgg 1560
ggctgcggga acagcctgcg tacggctctc atcaactcca ctggggaaga agtggccatg 1620
cgcaagctgg tgcgctcagt gactgtggtt gaggacgacg aggatgagga tggagatgac 1680
ctgctccatc accaccacgg ctcccactgc agcagctcgg gggaccccgc tgagtacaac 1740
ctgcgctcgc gcaccgtgct gtgcgggacc tgcgggcagc ctgccgacaa ggcatctgcc 1800
agcggctcag gagcccaggt gggcggaccc atctcctctg gctcttctgc ctccagtgtc 1860
acggtcactc gcagctaccg cagtgtgggg ggcagtgggg gtggcagctt cggggacaat 1920
ctggtcaccc gctcctacct cctgggcaac tccagccccc gaacccagag cccccagaac 1980
tgcagcatca tgtaa 1995
<210> 10
<211> 320
<212> PRT
<213> human
<400> 10
Met Glu Thr Pro Ser Gln Arg Arg Ala Thr Arg Ser Gly Ala Gln Ala
1 5 10 15
Ser Ser Thr Pro Leu Ser Pro Thr Arg Ile Thr Arg Leu Gln Glu Lys
20 25 30
Glu Asp Leu Gln Glu Leu Asn Asp Arg Leu Ala Val Tyr Ile Asp Arg
35 40 45
Val Arg Ser Leu Glu Thr Glu Asn Ala Gly Leu Arg Leu Arg Ile Thr
50 55 60
Glu Ser Glu Glu Val Val Ser Arg Glu Val Ser Gly Ile Lys Ala Ala
65 70 75 80
Tyr Glu Ala Glu Leu Gly Asp Ala Arg Lys Thr Leu Asp Ser Val Ala
85 90 95
Lys Glu Arg Ala Arg Leu Gln Leu Glu Leu Ser Lys Val Arg Glu Glu
100 105 110
Phe Lys Glu Leu Lys Ala Arg Asn Thr Lys Lys Glu Gly Asp Leu Ile
115 120 125
Ala Ala Gln Ala Arg Leu Lys Asp Leu Glu Ala Leu Leu Asn Ser Lys
130 135 140
Glu Ala Ala Leu Ser Thr Ala Leu Ser Glu Lys Arg Thr Leu Glu Gly
145 150 155 160
Glu Leu His Asp Leu Arg Gly Gln Val Ala Lys Leu Glu Ala Ala Leu
165 170 175
Gly Glu Ala Lys Lys Gln Leu Gln Asp Glu Met Leu Arg Arg Val Asp
180 185 190
Ala Glu Asn Arg Leu Gln Thr Met Lys Glu Glu Leu Asp Phe Gln Lys
195 200 205
Asn Ile Tyr Ser Glu Glu Leu Arg Glu Thr Lys Arg Arg His Glu Thr
210 215 220
Arg Leu Val Glu Ile Asp Asn Gly Lys Gln Arg Glu Phe Glu Ser Arg
225 230 235 240
Leu Ala Asp Ala Leu Gln Glu Leu Arg Ala Gln His Glu Asp Gln Val
245 250 255
Glu Gln Tyr Lys Lys Glu Leu Glu Lys Thr Tyr Ser Ala Lys Leu Asp
260 265 270
Asn Ala Arg Gln Ser Ala Glu Arg Asn Ser Asn Leu Val Gly Ala Ala
275 280 285
His Glu Glu Leu Gln Gln Ser Arg Ile Arg Ile Asp Ser Leu Ser Ala
290 295 300
Gln Leu Ser Gln Leu Gln Lys Gln Leu Ala Ala Lys Glu Ala Lys Leu
305 310 315 320
<210> 11
<211> 18
<212> DNA
<213> 人工序列
<400> 11
cctctctgcc cagctcag 18
<210> 12
<211> 20
<212> DNA
<213> 人工序列
<400> 12
gccagcttga tgtccagaag 20
<210> 13
<211> 5808
<212> DNA
<213> human
<400> 13
atgggagatt cggagatggc agtctttggg gctgccgccc cctacctgcg caagtcagag 60
aaggagcggc tagaagcgca gaccaggcct tttgacctca agaaggatgt cttcgtgcct 120
gatgacaaac aggagtttgt caaggccaag atcgtgtctc gagagggtgg caaagtcact 180
gccgagaccg agtatggcaa gacagtgacc gtgaaggagg accaggtgat gcagcagaac 240
ccacccaagt tcgacaaaat cgaggacatg gccatgctga ccttcctgca tgagcccgcg 300
gtgctctaca acctcaagga tcgctacggc tcctggatga tctacaccta ctcgggcctc 360
ttctgtgtca ccgtcaaccc ttacaagtgg ctgccggtgt acactcctga ggtggtggct 420
gcctaccggg gcaagaagag gagcgaggcc ccgccccaca tcttctccat ctccgacaac 480
gcctatcagt acatgctgac agacagagaa aaccagtcca tcctgatcac cggagaatcc 540
ggagcaggga agacagtcaa caccaagagg gtcatccagt actttgctgt tattgcagcc 600
attggggacc gcagcaagaa ggaccagagc ccgggcaagg gcaccctgga ggaccagatc 660
atccaggcca accctgctct ggaggccttt ggcaatgcca agaccgtccg gaacgacaac 720
tcctcccgct tcgggaaatt cattcgaatt cattttgggg caacaggaaa gttggcatct 780
gcagacatag agacctatct tctggaaaaa tccagagtta ttttccagct gaaagcagag 840
agagattatc acattttcta ccaaatcctg tctaacaaaa agcctgagct gctggacatg 900
ctgctgatca ccaacaaccc ctacgattat gcattcatct cccaaggaga gaccaccgtg 960
gcctccattg atgacgctga ggagctcatg gccactgata acgcttttga tgtgctgggc 1020
ttcacttcag aggagaaaaa ctccatgtat aagctgacag gcgccatcat gcactttgga 1080
aacatgaagt tcaagctgaa gcagcgggag gagcaggcgg agccagacgg cactgaagag 1140
gctgacaagt ctgcctacct catggggctg aactcagccg acctgctcaa ggggctgtgc 1200
caccctcggg tgaaagtggg caatgagtac gtcaccaagg ggcagaatgt ccagcaggtg 1260
atatatgcca ctggggcact ggccaaggca gtgtatgaga ggatgttcaa ctggatggtg 1320
acgcgcatca atgccaccct ggagaccaag cagccacgcc agtacttcat aggagtcctg 1380
gacatcgctg gcttcgagat cttcgatttc aacagctttg agcagctctg catcaacttc 1440
accaacgaga agctgcagca gttcttcaac caccacatgt ttgtgctgga gcaggaggag 1500
tacaagaagg agggcatcga gtggacattc attgactttg gcatggacct gcaggcctgc 1560
attgacctca tcgagaagcc catgggcatc atgtccatcc tggaagagga gtgcatgttc 1620
cccaaggcca ccgacatgac cttcaaggcc aagctgtttg acaaccacct gggcaaatcc 1680
gccaacttcc agaagccacg caatatcaag gggaagcctg aagcccactt ctccctgatc 1740
cactatgccg gcatcgtgga ctacaacatc attggctggc tgcagaagaa caaggatcct 1800
ctcaatgaga ctgtcgtggg cttgtatcag aagtcttccc tcaagctgct cagcaccctg 1860
tttgccaact atgctggggc tgatgcgcct attgagaagg gcaaaggcaa ggccaagaaa 1920
ggctcgtcct ttcagactgt gtcagctctg cacagggaaa atctgaacaa gctgatgacc 1980
aacttgcgct ccacccatcc ccactttgta cgttgtatca tccctaatga gacaaagtct 2040
ccaggggtga tggacaaccc cctggtcatg caccagctgc gctgcaatgg tgtgctggag 2100
ggcatccgca tctgcaggaa aggcttcccc aaccgcatcc tctacgggga cttccggcag 2160
aggtatcgca tcctgaaccc agcggccatc cctgagggac agttcattga tagcaggaag 2220
ggggcagaga agctgctcag ctccctggac attgatcaca accagtacaa gtttggccac 2280
accaaggtgt tcttcaaggc cgggctgctg gggctgctgg aggaaatgag ggacgagagg 2340
ctgagccgca tcatcacgcg tatccaggcc cagtcccgag gtgtgctcgc cagaatggag 2400
tacaaaaagc tgctggaacg tagagactcc ctgctggtaa tccagtggaa cattcgggcc 2460
ttcatggggg tcaagaattg gccctggatg aagctctact tcaagatcaa gccgctgctg 2520
aagagtgcag aaagagagaa ggagatggcc tccatgaagg aggagttcac acgcctcaaa 2580
gaggcgctag agaagtccga ggctcgccgc aaggagctgg aggagaagat ggtgtccctg 2640
ctgcaggaga agaatgacct gcagctccaa gtgcaggcgg aacaagacaa cctggcagat 2700
gctgaggagc gctgtgatca gctgatcaaa aacaagattc agctggaggc caaggtgaag 2760
gagatgaacg agaggctgga ggatgaggag gagatgaatg ctgagctcac tgccaagaag 2820
cgcaagctgg aagatgagtg ctcagagctc aaaagggaca tcgatgatct ggagctgaca 2880
ctggccaaag tggagaagga gaaacacgca acagagaaca aggtgaaaaa cctgacagag 2940
gagatggctg ggctggatga gatcattgcc aagctgacca aggagaagaa agctctgcaa 3000
gaggcccacc aacaggctct ggatgacctt caggccgagg aggacaaggt caacaccctg 3060
actaaggcca aagtcaagct ggagcagcaa gtggatgatc tggaaggatc cctggagcaa 3120
gagaagaagg tgcgcatgga cctggagcga gcgaagcgga agctggaggg cgacctgaag 3180
ctgacccagg agagcatcat ggacctggag aatgacaagc agcagctgga tgagcggctg 3240
aaaaaaaaag actttgagct gaatgctctc aacgcaagga ttgaggatga acaggccctc 3300
ggcagccagc tgcagaagaa gctcaaggag cttcaggcac gcatcgagga gctggaggag 3360
gagctggagg ccgagcgcac cgccagggct aaggtggaga agctgcgctc agacctgtct 3420
cgggagctgg aggagatcag cgagcggctg gaagaggccg gcggggccac gtccgtgcag 3480
atcgagatga acaagaagcg cgaggccgag ttccagaaga tgcggcggga cctggaggag 3540
gccacgctgc agcacgaggc cactgccgcg gccctgcgca agaagcacgc cgacagcgtg 3600
gccgagctgg gcgagcagat cgacaacctg cagcgggtga agcagaagct ggagaaggag 3660
aagagcgagt tcaagctgga gctggatgac gtcacctcca acatggagca gatcatcaag 3720
gccaaggcta acctggagaa gatgtgccgg accttggaag accagatgaa tgagcaccgg 3780
agcaaggcgg aggagaccca gcgttctgtc aacgacctca ccagccagcg ggccaagttg 3840
caaaccgaga atggtgagct gtcccggcag ctggatgaga aggaggcact gatctcccag 3900
ctgacccgag gcaagctcac ctacacccag cagctggagg acctcaagag gcagctggag 3960
gaggaggtta aggcgaagaa cgccctggcc cacgcactgc agtcggcccg gcatgactgc 4020
gacctgctgc gggagcagta cgaggaggag acggaggcca aggccgagct gcagcgcgtc 4080
ctttccaagg ccaactcgga ggtggcccag tggaggacca agtatgagac ggacgccatt 4140
cagcggactg aggagctcga ggaggccaag aagaagctgg cccagcggct gcaggaagct 4200
gaggaggccg tggaggctgt taatgccaag tgctcctcgc tggagaagac caagcaccgg 4260
ctacagaatg agatcgagga cttgatggtg gacgtagagc gctccaatgc tgctgctgca 4320
gccctggaca agaagcagag gaacttcgac aagatcctgg ccgagtggaa gcagaagtat 4380
gaggagtcgc agtcggagct ggagtcctcg cagaaggagg ctcgctccct cagcacagag 4440
ctcttcaaac tcaagaacgc ctatgaggag tccctggaac atctggagac cttcaagcgg 4500
gagaacaaaa acctgcagga ggagatctcc gacttgactg agcagttggg ttccagcgga 4560
aagactatcc atgagctgga gaaggtccga aagcagctgg aggccgagaa gatggagctg 4620
cagtcagccc tggaggaggc cgaggcctcc ctggagcacg aggagggcaa gatcctccgg 4680
gcccagctgg agttcaacca gatcaaggca gagatcgagc ggaagctggc agagaaggac 4740
gaggagatgg aacaggccaa gcgcaaccac ctgcgggtgg tggactcgct gcagacctcc 4800
ctggacgcag agacacgcag ccgcaacgag gccctgaggg tgaagaagaa gatggaagga 4860
gacctcaatg agatggagat ccagctcagc cacgccaacc gcatggccgc cgaggcccag 4920
aagcaagtca agagcctcca gagcttgttg aaggacaccc agattcagct ggacgatgca 4980
gtccgtgcca acgacgacct gaaggagaac atcgccatcg tggagcggcg caacaacctg 5040
ctgcaggctg agctggagga gttgcgtgcc gtggtggagc agacagagcg gtcccggaag 5100
ctggcggagc aggagctgat tgagactagt gagcgggtgc agctgctgca ttcccagaac 5160
accagcctca tcaaccagaa gaagaagatg gatgctgacc tgtcccagct ccagactgaa 5220
gtggaggagg cagtgcagga gtgcaggaat gctgaggaga aggccaagaa ggccatcacg 5280
gatgccgcca tgatggcaga ggagctgaag aaggagcagg acaccagcgc ccacctggag 5340
cgcatgaaga agaacatgga acagaccatt aaggacctgc agcaccggct ggacgaagcc 5400
gagcagatcg ccctcaaggg cggcaagaag cagctgcaga agctggaagc gcgggtgcgg 5460
gagctggaga atgagctgga ggccgagcag aagcgcaacg cagagtcggt gaagggcatg 5520
aggaagagcg agcggcgcat caaggagctc acctaccaga cggaggagga caggaaaaac 5580
ctgctgcggc tgcaggacct ggtagacaag ctgcagctaa aggtcaaggc ctacaagcgc 5640
caggccgagg aggcggagga gcaagccaac accaacctgt ccaagttccg caaggtgcag 5700
cacgagctgg atgaggcaga ggagcgggcg gacatcgccg agtcccaggt caacaagctg 5760
cgggccaaga gccgtgacat tggcacgaag ggcttgaatg aggagtag 5808
<210> 14
<211> 1935
<212> PRT
<213> human
<400> 14
Met Gly Asp Ser Glu Met Ala Val Phe Gly Ala Ala Ala Pro Tyr Leu
1 5 10 15
Arg Lys Ser Glu Lys Glu Arg Leu Glu Ala Gln Thr Arg Pro Phe Asp
20 25 30
Leu Lys Lys Asp Val Phe Val Pro Asp Asp Lys Gln Glu Phe Val Lys
35 40 45
Ala Lys Ile Val Ser Arg Glu Gly Gly Lys Val Thr Ala Glu Thr Glu
50 55 60
Tyr Gly Lys Thr Val Thr Val Lys Glu Asp Gln Val Met Gln Gln Asn
65 70 75 80
Pro Pro Lys Phe Asp Lys Ile Glu Asp Met Ala Met Leu Thr Phe Leu
85 90 95
His Glu Pro Ala Val Leu Tyr Asn Leu Lys Asp Arg Tyr Gly Ser Trp
100 105 110
Met Ile Tyr Thr Tyr Ser Gly Leu Phe Cys Val Thr Val Asn Pro Tyr
115 120 125
Lys Trp Leu Pro Val Tyr Thr Pro Glu Val Val Ala Ala Tyr Arg Gly
130 135 140
Lys Lys Arg Ser Glu Ala Pro Pro His Ile Phe Ser Ile Ser Asp Asn
145 150 155 160
Ala Tyr Gln Tyr Met Leu Thr Asp Arg Glu Asn Gln Ser Ile Leu Ile
165 170 175
Thr Gly Glu Ser Gly Ala Gly Lys Thr Val Asn Thr Lys Arg Val Ile
180 185 190
Gln Tyr Phe Ala Val Ile Ala Ala Ile Gly Asp Arg Ser Lys Lys Asp
195 200 205
Gln Ser Pro Gly Lys Gly Thr Leu Glu Asp Gln Ile Ile Gln Ala Asn
210 215 220
Pro Ala Leu Glu Ala Phe Gly Asn Ala Lys Thr Val Arg Asn Asp Asn
225 230 235 240
Ser Ser Arg Phe Gly Lys Phe Ile Arg Ile His Phe Gly Ala Thr Gly
245 250 255
Lys Leu Ala Ser Ala Asp Ile Glu Thr Tyr Leu Leu Glu Lys Ser Arg
260 265 270
Val Ile Phe Gln Leu Lys Ala Glu Arg Asp Tyr His Ile Phe Tyr Gln
275 280 285
Ile Leu Ser Asn Lys Lys Pro Glu Leu Leu Asp Met Leu Leu Ile Thr
290 295 300
Asn Asn Pro Tyr Asp Tyr Ala Phe Ile Ser Gln Gly Glu Thr Thr Val
305 310 315 320
Ala Ser Ile Asp Asp Ala Glu Glu Leu Met Ala Thr Asp Asn Ala Phe
325 330 335
Asp Val Leu Gly Phe Thr Ser Glu Glu Lys Asn Ser Met Tyr Lys Leu
340 345 350
Thr Gly Ala Ile Met His Phe Gly Asn Met Lys Phe Lys Leu Lys Gln
355 360 365
Arg Glu Glu Gln Ala Glu Pro Asp Gly Thr Glu Glu Ala Asp Lys Ser
370 375 380
Ala Tyr Leu Met Gly Leu Asn Ser Ala Asp Leu Leu Lys Gly Leu Cys
385 390 395 400
His Pro Arg Val Lys Val Gly Asn Glu Tyr Val Thr Lys Gly Gln Asn
405 410 415
Val Gln Gln Val Ile Tyr Ala Thr Gly Ala Leu Ala Lys Ala Val Tyr
420 425 430
Glu Arg Met Phe Asn Trp Met Val Thr Arg Ile Asn Ala Thr Leu Glu
435 440 445
Thr Lys Gln Pro Arg Gln Tyr Phe Ile Gly Val Leu Asp Ile Ala Gly
450 455 460
Phe Glu Ile Phe Asp Phe Asn Ser Phe Glu Gln Leu Cys Ile Asn Phe
465 470 475 480
Thr Asn Glu Lys Leu Gln Gln Phe Phe Asn His His Met Phe Val Leu
485 490 495
Glu Gln Glu Glu Tyr Lys Lys Glu Gly Ile Glu Trp Thr Phe Ile Asp
500 505 510
Phe Gly Met Asp Leu Gln Ala Cys Ile Asp Leu Ile Glu Lys Pro Met
515 520 525
Gly Ile Met Ser Ile Leu Glu Glu Glu Cys Met Phe Pro Lys Ala Thr
530 535 540
Asp Met Thr Phe Lys Ala Lys Leu Phe Asp Asn His Leu Gly Lys Ser
545 550 555 560
Ala Asn Phe Gln Lys Pro Arg Asn Ile Lys Gly Lys Pro Glu Ala His
565 570 575
Phe Ser Leu Ile His Tyr Ala Gly Ile Val Asp Tyr Asn Ile Ile Gly
580 585 590
Trp Leu Gln Lys Asn Lys Asp Pro Leu Asn Glu Thr Val Val Gly Leu
595 600 605
Tyr Gln Lys Ser Ser Leu Lys Leu Leu Ser Thr Leu Phe Ala Asn Tyr
610 615 620
Ala Gly Ala Asp Ala Pro Ile Glu Lys Gly Lys Gly Lys Ala Lys Lys
625 630 635 640
Gly Ser Ser Phe Gln Thr Val Ser Ala Leu His Arg Glu Asn Leu Asn
645 650 655
Lys Leu Met Thr Asn Leu Arg Ser Thr His Pro His Phe Val Arg Cys
660 665 670
Ile Ile Pro Asn Glu Thr Lys Ser Pro Gly Val Met Asp Asn Pro Leu
675 680 685
Val Met His Gln Leu Arg Cys Asn Gly Val Leu Glu Gly Ile Arg Ile
690 695 700
Cys Arg Lys Gly Phe Pro Asn Arg Ile Leu Tyr Gly Asp Phe Arg Gln
705 710 715 720
Arg Tyr Arg Ile Leu Asn Pro Ala Ala Ile Pro Glu Gly Gln Phe Ile
725 730 735
Asp Ser Arg Lys Gly Ala Glu Lys Leu Leu Ser Ser Leu Asp Ile Asp
740 745 750
His Asn Gln Tyr Lys Phe Gly His Thr Lys Val Phe Phe Lys Ala Gly
755 760 765
Leu Leu Gly Leu Leu Glu Glu Met Arg Asp Glu Arg Leu Ser Arg Ile
770 775 780
Ile Thr Arg Ile Gln Ala Gln Ser Arg Gly Val Leu Ala Arg Met Glu
785 790 795 800
Tyr Lys Lys Leu Leu Glu Arg Arg Asp Ser Leu Leu Val Ile Gln Trp
805 810 815
Asn Ile Arg Ala Phe Met Gly Val Lys Asn Trp Pro Trp Met Lys Leu
820 825 830
Tyr Phe Lys Ile Lys Pro Leu Leu Lys Ser Ala Glu Arg Glu Lys Glu
835 840 845
Met Ala Ser Met Lys Glu Glu Phe Thr Arg Leu Lys Glu Ala Leu Glu
850 855 860
Lys Ser Glu Ala Arg Arg Lys Glu Leu Glu Glu Lys Met Val Ser Leu
865 870 875 880
Leu Gln Glu Lys Asn Asp Leu Gln Leu Gln Val Gln Ala Glu Gln Asp
885 890 895
Asn Leu Ala Asp Ala Glu Glu Arg Cys Asp Gln Leu Ile Lys Asn Lys
900 905 910
Ile Gln Leu Glu Ala Lys Val Lys Glu Met Asn Glu Arg Leu Glu Asp
915 920 925
Glu Glu Glu Met Asn Ala Glu Leu Thr Ala Lys Lys Arg Lys Leu Glu
930 935 940
Asp Glu Cys Ser Glu Leu Lys Arg Asp Ile Asp Asp Leu Glu Leu Thr
945 950 955 960
Leu Ala Lys Val Glu Lys Glu Lys His Ala Thr Glu Asn Lys Val Lys
965 970 975
Asn Leu Thr Glu Glu Met Ala Gly Leu Asp Glu Ile Ile Ala Lys Leu
980 985 990
Thr Lys Glu Lys Lys Ala Leu Gln Glu Ala His Gln Gln Ala Leu Asp
995 1000 1005
Asp Leu Gln Ala Glu Glu Asp Lys Val Asn Thr Leu Thr Lys Ala
1010 1015 1020
Lys Val Lys Leu Glu Gln Gln Val Asp Asp Leu Glu Gly Ser Leu
1025 1030 1035
Glu Gln Glu Lys Lys Val Arg Met Asp Leu Glu Arg Ala Lys Arg
1040 1045 1050
Lys Leu Glu Gly Asp Leu Lys Leu Thr Gln Glu Ser Ile Met Asp
1055 1060 1065
Leu Glu Asn Asp Lys Gln Gln Leu Asp Glu Arg Leu Lys Lys Lys
1070 1075 1080
Asp Phe Glu Leu Asn Ala Leu Asn Ala Arg Ile Glu Asp Glu Gln
1085 1090 1095
Ala Leu Gly Ser Gln Leu Gln Lys Lys Leu Lys Glu Leu Gln Ala
1100 1105 1110
Arg Ile Glu Glu Leu Glu Glu Glu Leu Glu Ala Glu Arg Thr Ala
1115 1120 1125
Arg Ala Lys Val Glu Lys Leu Arg Ser Asp Leu Ser Arg Glu Leu
1130 1135 1140
Glu Glu Ile Ser Glu Arg Leu Glu Glu Ala Gly Gly Ala Thr Ser
1145 1150 1155
Val Gln Ile Glu Met Asn Lys Lys Arg Glu Ala Glu Phe Gln Lys
1160 1165 1170
Met Arg Arg Asp Leu Glu Glu Ala Thr Leu Gln His Glu Ala Thr
1175 1180 1185
Ala Ala Ala Leu Arg Lys Lys His Ala Asp Ser Val Ala Glu Leu
1190 1195 1200
Gly Glu Gln Ile Asp Asn Leu Gln Arg Val Lys Gln Lys Leu Glu
1205 1210 1215
Lys Glu Lys Ser Glu Phe Lys Leu Glu Leu Asp Asp Val Thr Ser
1220 1225 1230
Asn Met Glu Gln Ile Ile Lys Ala Lys Ala Asn Leu Glu Lys Met
1235 1240 1245
Cys Arg Thr Leu Glu Asp Gln Met Asn Glu His Arg Ser Lys Ala
1250 1255 1260
Glu Glu Thr Gln Arg Ser Val Asn Asp Leu Thr Ser Gln Arg Ala
1265 1270 1275
Lys Leu Gln Thr Glu Asn Gly Glu Leu Ser Arg Gln Leu Asp Glu
1280 1285 1290
Lys Glu Ala Leu Ile Ser Gln Leu Thr Arg Gly Lys Leu Thr Tyr
1295 1300 1305
Thr Gln Gln Leu Glu Asp Leu Lys Arg Gln Leu Glu Glu Glu Val
1310 1315 1320
Lys Ala Lys Asn Ala Leu Ala His Ala Leu Gln Ser Ala Arg His
1325 1330 1335
Asp Cys Asp Leu Leu Arg Glu Gln Tyr Glu Glu Glu Thr Glu Ala
1340 1345 1350
Lys Ala Glu Leu Gln Arg Val Leu Ser Lys Ala Asn Ser Glu Val
1355 1360 1365
Ala Gln Trp Arg Thr Lys Tyr Glu Thr Asp Ala Ile Gln Arg Thr
1370 1375 1380
Glu Glu Leu Glu Glu Ala Lys Lys Lys Leu Ala Gln Arg Leu Gln
1385 1390 1395
Glu Ala Glu Glu Ala Val Glu Ala Val Asn Ala Lys Cys Ser Ser
1400 1405 1410
Leu Glu Lys Thr Lys His Arg Leu Gln Asn Glu Ile Glu Asp Leu
1415 1420 1425
Met Val Asp Val Glu Arg Ser Asn Ala Ala Ala Ala Ala Leu Asp
1430 1435 1440
Lys Lys Gln Arg Asn Phe Asp Lys Ile Leu Ala Glu Trp Lys Gln
1445 1450 1455
Lys Tyr Glu Glu Ser Gln Ser Glu Leu Glu Ser Ser Gln Lys Glu
1460 1465 1470
Ala Arg Ser Leu Ser Thr Glu Leu Phe Lys Leu Lys Asn Ala Tyr
1475 1480 1485
Glu Glu Ser Leu Glu His Leu Glu Thr Phe Lys Arg Glu Asn Lys
1490 1495 1500
Asn Leu Gln Glu Glu Ile Ser Asp Leu Thr Glu Gln Leu Gly Ser
1505 1510 1515
Ser Gly Lys Thr Ile His Glu Leu Glu Lys Val Arg Lys Gln Leu
1520 1525 1530
Glu Ala Glu Lys Met Glu Leu Gln Ser Ala Leu Glu Glu Ala Glu
1535 1540 1545
Ala Ser Leu Glu His Glu Glu Gly Lys Ile Leu Arg Ala Gln Leu
1550 1555 1560
Glu Phe Asn Gln Ile Lys Ala Glu Ile Glu Arg Lys Leu Ala Glu
1565 1570 1575
Lys Asp Glu Glu Met Glu Gln Ala Lys Arg Asn His Leu Arg Val
1580 1585 1590
Val Asp Ser Leu Gln Thr Ser Leu Asp Ala Glu Thr Arg Ser Arg
1595 1600 1605
Asn Glu Ala Leu Arg Val Lys Lys Lys Met Glu Gly Asp Leu Asn
1610 1615 1620
Glu Met Glu Ile Gln Leu Ser His Ala Asn Arg Met Ala Ala Glu
1625 1630 1635
Ala Gln Lys Gln Val Lys Ser Leu Gln Ser Leu Leu Lys Asp Thr
1640 1645 1650
Gln Ile Gln Leu Asp Asp Ala Val Arg Ala Asn Asp Asp Leu Lys
1655 1660 1665
Glu Asn Ile Ala Ile Val Glu Arg Arg Asn Asn Leu Leu Gln Ala
1670 1675 1680
Glu Leu Glu Glu Leu Arg Ala Val Val Glu Gln Thr Glu Arg Ser
1685 1690 1695
Arg Lys Leu Ala Glu Gln Glu Leu Ile Glu Thr Ser Glu Arg Val
1700 1705 1710
Gln Leu Leu His Ser Gln Asn Thr Ser Leu Ile Asn Gln Lys Lys
1715 1720 1725
Lys Met Asp Ala Asp Leu Ser Gln Leu Gln Thr Glu Val Glu Glu
1730 1735 1740
Ala Val Gln Glu Cys Arg Asn Ala Glu Glu Lys Ala Lys Lys Ala
1745 1750 1755
Ile Thr Asp Ala Ala Met Met Ala Glu Glu Leu Lys Lys Glu Gln
1760 1765 1770
Asp Thr Ser Ala His Leu Glu Arg Met Lys Lys Asn Met Glu Gln
1775 1780 1785
Thr Ile Lys Asp Leu Gln His Arg Leu Asp Glu Ala Glu Gln Ile
1790 1795 1800
Ala Leu Lys Gly Gly Lys Lys Gln Leu Gln Lys Leu Glu Ala Arg
1805 1810 1815
Val Arg Glu Leu Glu Asn Glu Leu Glu Ala Glu Gln Lys Arg Asn
1820 1825 1830
Ala Glu Ser Val Lys Gly Met Arg Lys Ser Glu Arg Arg Ile Lys
1835 1840 1845
Glu Leu Thr Tyr Gln Thr Glu Glu Asp Arg Lys Asn Leu Leu Arg
1850 1855 1860
Leu Gln Asp Leu Val Asp Lys Leu Gln Leu Lys Val Lys Ala Tyr
1865 1870 1875
Lys Arg Gln Ala Glu Glu Ala Glu Glu Gln Ala Asn Thr Asn Leu
1880 1885 1890
Ser Lys Phe Arg Lys Val Gln His Glu Leu Asp Glu Ala Glu Glu
1895 1900 1905
Arg Ala Asp Ile Ala Glu Ser Gln Val Asn Lys Leu Arg Ala Lys
1910 1915 1920
Ser Arg Asp Ile Gly Thr Lys Gly Leu Asn Glu Glu
1925 1930 1935
<210> 15
<211> 5808
<212> DNA
<213> human
<400> 15
atgggagatt cggagatggc agtctttggg gctgccgccc cctacctgcg caagtcagag 60
aaggagcggc tagaagcgca gaccaggcct tttgacctca agaaggatgt cttcgtgcct 120
gatgacaaac aggagtttgt caaggccaag atcgtgtctc gagagggtgg caaagtcact 180
gccgagaccg agtatggcaa gacagtgacc gtgaaggagg accaggtgat gcagcagaac 240
ccacccaagt tcgacaaaat cgaggacatg gccatgctga ccttcctgca tgagcccgcg 300
gtgctctaca acctcaagga tcgctacggc tcctggatga tctacaccta ctcgggcctc 360
ttctgtgtca ccgtcaaccc ttacaagtgg ctgccggtgt acactcctga ggtggtggct 420
gcctaccggg gcaagaagag gagcgaggcc ccgccccaca tcttctccat ctccgacaac 480
gcctatcagt acatgctgac agacagagaa aaccagtcca tcctgatcac cggagaatcc 540
ggagcaggga agacagtcaa caccaagagg gtcatccagt actttgctgt tattgcagcc 600
attggggacc gcagcaagaa ggaccagagc ccgggcaagg gcaccctgga ggaccagatc 660
atccaggcca accctgctct ggaggccttt ggcaatgcca agaccgtccg gaacgacaac 720
tcctcccgct tcgggaaatt cattcgaatt cattttgggg caacaggaaa gttggcatct 780
gcagacatag agacctatct tctggaaaaa tccagagtta ttttccagct gaaagcagag 840
agagattatc acattttcta ccaaatcctg tctaacaaaa agcctgagct gctggacatg 900
ctgctgatca ccaacaaccc ctacgattat gcattcatct cccaaggaga gaccaccgtg 960
gcctccattg atgacgctga ggagctcatg gccactgata acgcttttga tgtgctgggc 1020
ttcacttcag aggagaaaaa ctccatgtat aagctgacag gcgccatcat gcactttgga 1080
aacatgaagt tcaagctgaa gcagcgggag gagcaggcgg agccagacgg cactgaagag 1140
gctgacaagt ctgcctacct catggggctg aactcagccg acctgctcaa ggggctgtgc 1200
caccctcggg tgaaagtggg caatgagtac gtcaccaagg ggcagaatgt ccagcaggtg 1260
atatatgcca ctggggcact ggccaaggca gtgtatgaga ggatgttcaa ctggatggtg 1320
acgcgcatca atgccaccct ggagaccaag cagccacgcc agtacttcat aggagtcctg 1380
gacatcgctg gcttcgagat cttcgatttc aacagctttg agcagctctg catcaacttc 1440
accaacgaga agctgcagca gttcttcaac caccacatgt ttgtgctgga gcaggaggag 1500
tacaagaagg agggcatcga gtggacattc attgactttg gcatggacct gcaggcctgc 1560
attgacctca tcgagaagcc catgggcatc atgtccatcc tggaagagga gtgcatgttc 1620
cccaaggcca ccgacatgac cttcaaggcc aagctgtttg acaaccacct gggcaaatcc 1680
gccaacttcc agaagccacg caatatcaag gggaagcctg aagcccactt ctccctgatc 1740
cactatgccg gcatcgtgga ctacaacatc attggctggc tgcagaagaa caaggatcct 1800
ctcaatgaga ctgtcgtggg cttgtatcag aagtcttccc tcaagctgct cagcaccctg 1860
tttgccaact atgctggggc tgatgcgcct attgagaagg gcaaaggcaa ggccaagaaa 1920
ggctcgtcct ttcagactgt gtcagctctg cacagggaaa atctgaacaa gctgatgacc 1980
aacttgcgct ccacccatcc ccactttgta cgttgtatca tccctaatga gacaaagtct 2040
ccaggggtga tggacaaccc cctggtcatg caccagctgc gctgcaatgg tgtgctggag 2100
ggcatccgca tctgcaggaa aggcttcccc aaccgcatcc tctacgggga cttccggcag 2160
aggtatcgca tcctgaaccc agcggccatc cctgagggac agttcattga tagcaggaag 2220
ggggcagaga agctgctcag ctccctggac attgatcaca accagtacaa gtttggccac 2280
accaaggtgt tcttcaaggc cgggctgctg gggctgctgg aggaaatgag ggacgagagg 2340
ctgagccgca tcatcacgcg tatccaggcc cagtcccgag gtgtgctcgc cagaatggag 2400
tacaaaaagc tgctggaacg tagagactcc ctgctggtaa tccagtggaa cattcggccc 2460
ttcatggggg tcaagaattg gccctggatg aagctctact tcaagatcaa gccgctgctg 2520
aagagtgcag aaagagagaa ggagatggcc tccatgaagg aggagttcac acgcctcaaa 2580
gaggcgctag agaagtccga ggctcgccgc aaggagctgg aggagaagat ggtgtccctg 2640
ctgcaggaga agaatgacct gcagctccaa gtgcaggcgg aacaagacaa cctggcagat 2700
gctgaggagc gctgtgatca gctgatcaaa aacaagattc agctggaggc caaggtgaag 2760
gagatgaacg agaggctgga ggatgaggag gagatgaatg ctgagctcac tgccaagaag 2820
cgcaagctgg aagatgagtg ctcagagctc aaaagggaca tcgatgatct ggagctgaca 2880
ctggccaaag tggagaagga gaaacacgca acagagaaca aggtgaaaaa cctgacagag 2940
gagatggctg ggctggatga gatcattgcc aagctgacca aggagaagaa agctctgcaa 3000
gaggcccacc aacaggctct ggatgacctt caggccgagg aggacaaggt caacaccctg 3060
actaaggcca aagtcaagct ggagcagcaa gtggatgatc tggaaggatc cctggagcaa 3120
gagaagaagg tgcgcatgga cctggagcga gcgaagcgga agctggaggg cgacctgaag 3180
ctgacccagg agagcatcat ggacctggag aatgacaagc agcagctgga tgagcggctg 3240
aaaaaaaaag actttgagct gaatgctctc aacgcaagga ttgaggatga acaggccctc 3300
ggcagccagc tgcagaagaa gctcaaggag cttcaggcac gcatcgagga gctggaggag 3360
gagctggagg ccgagcgcac cgccagggct aaggtggaga agctgcgctc agacctgtct 3420
cgggagctgg aggagatcag cgagcggctg gaagaggccg gcggggccac gtccgtgcag 3480
atcgagatga acaagaagcg cgaggccgag ttccagaaga tgcggcggga cctggaggag 3540
gccacgctgc agcacgaggc cactgccgcg gccctgcgca agaagcacgc cgacagcgtg 3600
gccgagctgg gcgagcagat cgacaacctg cagcgggtga agcagaagct ggagaaggag 3660
aagagcgagt tcaagctgga gctggatgac gtcacctcca acatggagca gatcatcaag 3720
gccaaggcta acctggagaa gatgtgccgg accttggaag accagatgaa tgagcaccgg 3780
agcaaggcgg aggagaccca gcgttctgtc aacgacctca ccagccagcg ggccaagttg 3840
caaaccgaga atggtgagct gtcccggcag ctggatgaga aggaggcact gatctcccag 3900
ctgacccgag gcaagctcac ctacacccag cagctggagg acctcaagag gcagctggag 3960
gaggaggtta aggcgaagaa cgccctggcc cacgcactgc agtcggcccg gcatgactgc 4020
gacctgctgc gggagcagta cgaggaggag acggaggcca aggccgagct gcagcgcgtc 4080
ctttccaagg ccaactcgga ggtggcccag tggaggacca agtatgagac ggacgccatt 4140
cagcggactg aggagctcga ggaggccaag aagaagctgg cccagcggct gcaggaagct 4200
gaggaggccg tggaggctgt taatgccaag tgctcctcgc tggagaagac caagcaccgg 4260
ctacagaatg agatcgagga cttgatggtg gacgtagagc gctccaatgc tgctgctgca 4320
gccctggaca agaagcagag gaacttcgac aagatcctgg ccgagtggaa gcagaagtat 4380
gaggagtcgc agtcggagct ggagtcctcg cagaaggagg ctcgctccct cagcacagag 4440
ctcttcaaac tcaagaacgc ctatgaggag tccctggaac atctggagac cttcaagcgg 4500
gagaacaaaa acctgcagga ggagatctcc gacttgactg agcagttggg ttccagcgga 4560
aagactatcc atgagctgga gaaggtccga aagcagctgg aggccgagaa gatggagctg 4620
cagtcagccc tggaggaggc cgaggcctcc ctggagcacg aggagggcaa gatcctccgg 4680
gcccagctgg agttcaacca gatcaaggca gagatcgagc ggaagctggc agagaaggac 4740
gaggagatgg aacaggccaa gcgcaaccac ctgcgggtgg tggactcgct gcagacctcc 4800
ctggacgcag agacacgcag ccgcaacgag gccctgaggg tgaagaagaa gatggaagga 4860
gacctcaatg agatggagat ccagctcagc cacgccaacc gcatggccgc cgaggcccag 4920
aagcaagtca agagcctcca gagcttgttg aaggacaccc agattcagct ggacgatgca 4980
gtccgtgcca acgacgacct gaaggagaac atcgccatcg tggagcggcg caacaacctg 5040
ctgcaggctg agctggagga gttgcgtgcc gtggtggagc agacagagcg gtcccggaag 5100
ctggcggagc aggagctgat tgagactagt gagcgggtgc agctgctgca ttcccagaac 5160
accagcctca tcaaccagaa gaagaagatg gatgctgacc tgtcccagct ccagactgaa 5220
gtggaggagg cagtgcagga gtgcaggaat gctgaggaga aggccaagaa ggccatcacg 5280
gatgccgcca tgatggcaga ggagctgaag aaggagcagg acaccagcgc ccacctggag 5340
cgcatgaaga agaacatgga acagaccatt aaggacctgc agcaccggct ggacgaagcc 5400
gagcagatcg ccctcaaggg cggcaagaag cagctgcaga agctggaagc gcgggtgcgg 5460
gagctggaga atgagctgga ggccgagcag aagcgcaacg cagagtcggt gaagggcatg 5520
aggaagagcg agcggcgcat caaggagctc acctaccaga cggaggagga caggaaaaac 5580
ctgctgcggc tgcaggacct ggtagacaag ctgcagctaa aggtcaaggc ctacaagcgc 5640
caggccgagg aggcggagga gcaagccaac accaacctgt ccaagttccg caaggtgcag 5700
cacgagctgg atgaggcaga ggagcgggcg gacatcgccg agtcccaggt caacaagctg 5760
cgggccaaga gccgtgacat tggcacgaag ggcttgaatg aggagtag 5808
<210> 16
<211> 1935
<212> PRT
<213> human
<400> 16
Met Gly Asp Ser Glu Met Ala Val Phe Gly Ala Ala Ala Pro Tyr Leu
1 5 10 15
Arg Lys Ser Glu Lys Glu Arg Leu Glu Ala Gln Thr Arg Pro Phe Asp
20 25 30
Leu Lys Lys Asp Val Phe Val Pro Asp Asp Lys Gln Glu Phe Val Lys
35 40 45
Ala Lys Ile Val Ser Arg Glu Gly Gly Lys Val Thr Ala Glu Thr Glu
50 55 60
Tyr Gly Lys Thr Val Thr Val Lys Glu Asp Gln Val Met Gln Gln Asn
65 70 75 80
Pro Pro Lys Phe Asp Lys Ile Glu Asp Met Ala Met Leu Thr Phe Leu
85 90 95
His Glu Pro Ala Val Leu Tyr Asn Leu Lys Asp Arg Tyr Gly Ser Trp
100 105 110
Met Ile Tyr Thr Tyr Ser Gly Leu Phe Cys Val Thr Val Asn Pro Tyr
115 120 125
Lys Trp Leu Pro Val Tyr Thr Pro Glu Val Val Ala Ala Tyr Arg Gly
130 135 140
Lys Lys Arg Ser Glu Ala Pro Pro His Ile Phe Ser Ile Ser Asp Asn
145 150 155 160
Ala Tyr Gln Tyr Met Leu Thr Asp Arg Glu Asn Gln Ser Ile Leu Ile
165 170 175
Thr Gly Glu Ser Gly Ala Gly Lys Thr Val Asn Thr Lys Arg Val Ile
180 185 190
Gln Tyr Phe Ala Val Ile Ala Ala Ile Gly Asp Arg Ser Lys Lys Asp
195 200 205
Gln Ser Pro Gly Lys Gly Thr Leu Glu Asp Gln Ile Ile Gln Ala Asn
210 215 220
Pro Ala Leu Glu Ala Phe Gly Asn Ala Lys Thr Val Arg Asn Asp Asn
225 230 235 240
Ser Ser Arg Phe Gly Lys Phe Ile Arg Ile His Phe Gly Ala Thr Gly
245 250 255
Lys Leu Ala Ser Ala Asp Ile Glu Thr Tyr Leu Leu Glu Lys Ser Arg
260 265 270
Val Ile Phe Gln Leu Lys Ala Glu Arg Asp Tyr His Ile Phe Tyr Gln
275 280 285
Ile Leu Ser Asn Lys Lys Pro Glu Leu Leu Asp Met Leu Leu Ile Thr
290 295 300
Asn Asn Pro Tyr Asp Tyr Ala Phe Ile Ser Gln Gly Glu Thr Thr Val
305 310 315 320
Ala Ser Ile Asp Asp Ala Glu Glu Leu Met Ala Thr Asp Asn Ala Phe
325 330 335
Asp Val Leu Gly Phe Thr Ser Glu Glu Lys Asn Ser Met Tyr Lys Leu
340 345 350
Thr Gly Ala Ile Met His Phe Gly Asn Met Lys Phe Lys Leu Lys Gln
355 360 365
Arg Glu Glu Gln Ala Glu Pro Asp Gly Thr Glu Glu Ala Asp Lys Ser
370 375 380
Ala Tyr Leu Met Gly Leu Asn Ser Ala Asp Leu Leu Lys Gly Leu Cys
385 390 395 400
His Pro Arg Val Lys Val Gly Asn Glu Tyr Val Thr Lys Gly Gln Asn
405 410 415
Val Gln Gln Val Ile Tyr Ala Thr Gly Ala Leu Ala Lys Ala Val Tyr
420 425 430
Glu Arg Met Phe Asn Trp Met Val Thr Arg Ile Asn Ala Thr Leu Glu
435 440 445
Thr Lys Gln Pro Arg Gln Tyr Phe Ile Gly Val Leu Asp Ile Ala Gly
450 455 460
Phe Glu Ile Phe Asp Phe Asn Ser Phe Glu Gln Leu Cys Ile Asn Phe
465 470 475 480
Thr Asn Glu Lys Leu Gln Gln Phe Phe Asn His His Met Phe Val Leu
485 490 495
Glu Gln Glu Glu Tyr Lys Lys Glu Gly Ile Glu Trp Thr Phe Ile Asp
500 505 510
Phe Gly Met Asp Leu Gln Ala Cys Ile Asp Leu Ile Glu Lys Pro Met
515 520 525
Gly Ile Met Ser Ile Leu Glu Glu Glu Cys Met Phe Pro Lys Ala Thr
530 535 540
Asp Met Thr Phe Lys Ala Lys Leu Phe Asp Asn His Leu Gly Lys Ser
545 550 555 560
Ala Asn Phe Gln Lys Pro Arg Asn Ile Lys Gly Lys Pro Glu Ala His
565 570 575
Phe Ser Leu Ile His Tyr Ala Gly Ile Val Asp Tyr Asn Ile Ile Gly
580 585 590
Trp Leu Gln Lys Asn Lys Asp Pro Leu Asn Glu Thr Val Val Gly Leu
595 600 605
Tyr Gln Lys Ser Ser Leu Lys Leu Leu Ser Thr Leu Phe Ala Asn Tyr
610 615 620
Ala Gly Ala Asp Ala Pro Ile Glu Lys Gly Lys Gly Lys Ala Lys Lys
625 630 635 640
Gly Ser Ser Phe Gln Thr Val Ser Ala Leu His Arg Glu Asn Leu Asn
645 650 655
Lys Leu Met Thr Asn Leu Arg Ser Thr His Pro His Phe Val Arg Cys
660 665 670
Ile Ile Pro Asn Glu Thr Lys Ser Pro Gly Val Met Asp Asn Pro Leu
675 680 685
Val Met His Gln Leu Arg Cys Asn Gly Val Leu Glu Gly Ile Arg Ile
690 695 700
Cys Arg Lys Gly Phe Pro Asn Arg Ile Leu Tyr Gly Asp Phe Arg Gln
705 710 715 720
Arg Tyr Arg Ile Leu Asn Pro Ala Ala Ile Pro Glu Gly Gln Phe Ile
725 730 735
Asp Ser Arg Lys Gly Ala Glu Lys Leu Leu Ser Ser Leu Asp Ile Asp
740 745 750
His Asn Gln Tyr Lys Phe Gly His Thr Lys Val Phe Phe Lys Ala Gly
755 760 765
Leu Leu Gly Leu Leu Glu Glu Met Arg Asp Glu Arg Leu Ser Arg Ile
770 775 780
Ile Thr Arg Ile Gln Ala Gln Ser Arg Gly Val Leu Ala Arg Met Glu
785 790 795 800
Tyr Lys Lys Leu Leu Glu Arg Arg Asp Ser Leu Leu Val Ile Gln Trp
805 810 815
Asn Ile Arg Pro Phe Met Gly Val Lys Asn Trp Pro Trp Met Lys Leu
820 825 830
Tyr Phe Lys Ile Lys Pro Leu Leu Lys Ser Ala Glu Arg Glu Lys Glu
835 840 845
Met Ala Ser Met Lys Glu Glu Phe Thr Arg Leu Lys Glu Ala Leu Glu
850 855 860
Lys Ser Glu Ala Arg Arg Lys Glu Leu Glu Glu Lys Met Val Ser Leu
865 870 875 880
Leu Gln Glu Lys Asn Asp Leu Gln Leu Gln Val Gln Ala Glu Gln Asp
885 890 895
Asn Leu Ala Asp Ala Glu Glu Arg Cys Asp Gln Leu Ile Lys Asn Lys
900 905 910
Ile Gln Leu Glu Ala Lys Val Lys Glu Met Asn Glu Arg Leu Glu Asp
915 920 925
Glu Glu Glu Met Asn Ala Glu Leu Thr Ala Lys Lys Arg Lys Leu Glu
930 935 940
Asp Glu Cys Ser Glu Leu Lys Arg Asp Ile Asp Asp Leu Glu Leu Thr
945 950 955 960
Leu Ala Lys Val Glu Lys Glu Lys His Ala Thr Glu Asn Lys Val Lys
965 970 975
Asn Leu Thr Glu Glu Met Ala Gly Leu Asp Glu Ile Ile Ala Lys Leu
980 985 990
Thr Lys Glu Lys Lys Ala Leu Gln Glu Ala His Gln Gln Ala Leu Asp
995 1000 1005
Asp Leu Gln Ala Glu Glu Asp Lys Val Asn Thr Leu Thr Lys Ala
1010 1015 1020
Lys Val Lys Leu Glu Gln Gln Val Asp Asp Leu Glu Gly Ser Leu
1025 1030 1035
Glu Gln Glu Lys Lys Val Arg Met Asp Leu Glu Arg Ala Lys Arg
1040 1045 1050
Lys Leu Glu Gly Asp Leu Lys Leu Thr Gln Glu Ser Ile Met Asp
1055 1060 1065
Leu Glu Asn Asp Lys Gln Gln Leu Asp Glu Arg Leu Lys Lys Lys
1070 1075 1080
Asp Phe Glu Leu Asn Ala Leu Asn Ala Arg Ile Glu Asp Glu Gln
1085 1090 1095
Ala Leu Gly Ser Gln Leu Gln Lys Lys Leu Lys Glu Leu Gln Ala
1100 1105 1110
Arg Ile Glu Glu Leu Glu Glu Glu Leu Glu Ala Glu Arg Thr Ala
1115 1120 1125
Arg Ala Lys Val Glu Lys Leu Arg Ser Asp Leu Ser Arg Glu Leu
1130 1135 1140
Glu Glu Ile Ser Glu Arg Leu Glu Glu Ala Gly Gly Ala Thr Ser
1145 1150 1155
Val Gln Ile Glu Met Asn Lys Lys Arg Glu Ala Glu Phe Gln Lys
1160 1165 1170
Met Arg Arg Asp Leu Glu Glu Ala Thr Leu Gln His Glu Ala Thr
1175 1180 1185
Ala Ala Ala Leu Arg Lys Lys His Ala Asp Ser Val Ala Glu Leu
1190 1195 1200
Gly Glu Gln Ile Asp Asn Leu Gln Arg Val Lys Gln Lys Leu Glu
1205 1210 1215
Lys Glu Lys Ser Glu Phe Lys Leu Glu Leu Asp Asp Val Thr Ser
1220 1225 1230
Asn Met Glu Gln Ile Ile Lys Ala Lys Ala Asn Leu Glu Lys Met
1235 1240 1245
Cys Arg Thr Leu Glu Asp Gln Met Asn Glu His Arg Ser Lys Ala
1250 1255 1260
Glu Glu Thr Gln Arg Ser Val Asn Asp Leu Thr Ser Gln Arg Ala
1265 1270 1275
Lys Leu Gln Thr Glu Asn Gly Glu Leu Ser Arg Gln Leu Asp Glu
1280 1285 1290
Lys Glu Ala Leu Ile Ser Gln Leu Thr Arg Gly Lys Leu Thr Tyr
1295 1300 1305
Thr Gln Gln Leu Glu Asp Leu Lys Arg Gln Leu Glu Glu Glu Val
1310 1315 1320
Lys Ala Lys Asn Ala Leu Ala His Ala Leu Gln Ser Ala Arg His
1325 1330 1335
Asp Cys Asp Leu Leu Arg Glu Gln Tyr Glu Glu Glu Thr Glu Ala
1340 1345 1350
Lys Ala Glu Leu Gln Arg Val Leu Ser Lys Ala Asn Ser Glu Val
1355 1360 1365
Ala Gln Trp Arg Thr Lys Tyr Glu Thr Asp Ala Ile Gln Arg Thr
1370 1375 1380
Glu Glu Leu Glu Glu Ala Lys Lys Lys Leu Ala Gln Arg Leu Gln
1385 1390 1395
Glu Ala Glu Glu Ala Val Glu Ala Val Asn Ala Lys Cys Ser Ser
1400 1405 1410
Leu Glu Lys Thr Lys His Arg Leu Gln Asn Glu Ile Glu Asp Leu
1415 1420 1425
Met Val Asp Val Glu Arg Ser Asn Ala Ala Ala Ala Ala Leu Asp
1430 1435 1440
Lys Lys Gln Arg Asn Phe Asp Lys Ile Leu Ala Glu Trp Lys Gln
1445 1450 1455
Lys Tyr Glu Glu Ser Gln Ser Glu Leu Glu Ser Ser Gln Lys Glu
1460 1465 1470
Ala Arg Ser Leu Ser Thr Glu Leu Phe Lys Leu Lys Asn Ala Tyr
1475 1480 1485
Glu Glu Ser Leu Glu His Leu Glu Thr Phe Lys Arg Glu Asn Lys
1490 1495 1500
Asn Leu Gln Glu Glu Ile Ser Asp Leu Thr Glu Gln Leu Gly Ser
1505 1510 1515
Ser Gly Lys Thr Ile His Glu Leu Glu Lys Val Arg Lys Gln Leu
1520 1525 1530
Glu Ala Glu Lys Met Glu Leu Gln Ser Ala Leu Glu Glu Ala Glu
1535 1540 1545
Ala Ser Leu Glu His Glu Glu Gly Lys Ile Leu Arg Ala Gln Leu
1550 1555 1560
Glu Phe Asn Gln Ile Lys Ala Glu Ile Glu Arg Lys Leu Ala Glu
1565 1570 1575
Lys Asp Glu Glu Met Glu Gln Ala Lys Arg Asn His Leu Arg Val
1580 1585 1590
Val Asp Ser Leu Gln Thr Ser Leu Asp Ala Glu Thr Arg Ser Arg
1595 1600 1605
Asn Glu Ala Leu Arg Val Lys Lys Lys Met Glu Gly Asp Leu Asn
1610 1615 1620
Glu Met Glu Ile Gln Leu Ser His Ala Asn Arg Met Ala Ala Glu
1625 1630 1635
Ala Gln Lys Gln Val Lys Ser Leu Gln Ser Leu Leu Lys Asp Thr
1640 1645 1650
Gln Ile Gln Leu Asp Asp Ala Val Arg Ala Asn Asp Asp Leu Lys
1655 1660 1665
Glu Asn Ile Ala Ile Val Glu Arg Arg Asn Asn Leu Leu Gln Ala
1670 1675 1680
Glu Leu Glu Glu Leu Arg Ala Val Val Glu Gln Thr Glu Arg Ser
1685 1690 1695
Arg Lys Leu Ala Glu Gln Glu Leu Ile Glu Thr Ser Glu Arg Val
1700 1705 1710
Gln Leu Leu His Ser Gln Asn Thr Ser Leu Ile Asn Gln Lys Lys
1715 1720 1725
Lys Met Asp Ala Asp Leu Ser Gln Leu Gln Thr Glu Val Glu Glu
1730 1735 1740
Ala Val Gln Glu Cys Arg Asn Ala Glu Glu Lys Ala Lys Lys Ala
1745 1750 1755
Ile Thr Asp Ala Ala Met Met Ala Glu Glu Leu Lys Lys Glu Gln
1760 1765 1770
Asp Thr Ser Ala His Leu Glu Arg Met Lys Lys Asn Met Glu Gln
1775 1780 1785
Thr Ile Lys Asp Leu Gln His Arg Leu Asp Glu Ala Glu Gln Ile
1790 1795 1800
Ala Leu Lys Gly Gly Lys Lys Gln Leu Gln Lys Leu Glu Ala Arg
1805 1810 1815
Val Arg Glu Leu Glu Asn Glu Leu Glu Ala Glu Gln Lys Arg Asn
1820 1825 1830
Ala Glu Ser Val Lys Gly Met Arg Lys Ser Glu Arg Arg Ile Lys
1835 1840 1845
Glu Leu Thr Tyr Gln Thr Glu Glu Asp Arg Lys Asn Leu Leu Arg
1850 1855 1860
Leu Gln Asp Leu Val Asp Lys Leu Gln Leu Lys Val Lys Ala Tyr
1865 1870 1875
Lys Arg Gln Ala Glu Glu Ala Glu Glu Gln Ala Asn Thr Asn Leu
1880 1885 1890
Ser Lys Phe Arg Lys Val Gln His Glu Leu Asp Glu Ala Glu Glu
1895 1900 1905
Arg Ala Asp Ile Ala Glu Ser Gln Val Asn Lys Leu Arg Ala Lys
1910 1915 1920
Ser Arg Asp Ile Gly Thr Lys Gly Leu Asn Glu Glu
1925 1930 1935
<210> 17
<211> 20
<212> DNA
<213> 人工序列
<400> 17
gactccctgc tggtaatcca 20
<210> 18
<211> 20
<212> DNA
<213> 人工序列
<400> 18
gactccctgc tggtaatcca 20

Claims (5)

1.一种分离的编码突变体的核酸分子,其特征在于,所述的核酸分子与SEQ ID NO:1相比,具有c.488 A>G突变。
2.一种分离的多肽,其特征在于,所述的多肽与SEQ ID NO:2相比,具有p.Glu 163 Gly突变。
3.一种试剂在制备筛查扩张型心肌病或筛选易患扩张型心肌病生物样品的试剂盒的应用,其特征在于,所述试剂检测Chmp4c基因与SEQ ID NO:1相比是否存在c.488 A>G突变的试剂。
4.根据权利要求3所述的应用,其特征在于,所述的扩张型心肌病为家族性扩张型心肌病。
5.根据权利要求3或4所述的应用,其特征在于,所述的扩张型心肌病其患病个体属于汉族人群。
CN201710732660.2A 2017-08-24 2017-08-24 汉族人群家族性扩张型心肌病的筛查试剂盒 Active CN107475259B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710732660.2A CN107475259B (zh) 2017-08-24 2017-08-24 汉族人群家族性扩张型心肌病的筛查试剂盒

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710732660.2A CN107475259B (zh) 2017-08-24 2017-08-24 汉族人群家族性扩张型心肌病的筛查试剂盒

Publications (2)

Publication Number Publication Date
CN107475259A CN107475259A (zh) 2017-12-15
CN107475259B true CN107475259B (zh) 2020-08-11

Family

ID=60602362

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710732660.2A Active CN107475259B (zh) 2017-08-24 2017-08-24 汉族人群家族性扩张型心肌病的筛查试剂盒

Country Status (1)

Country Link
CN (1) CN107475259B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108588085B (zh) * 2018-05-30 2021-11-09 上海市第十人民医院 恶性心律失常的筛查试剂盒、动物模型的建立方法及应用
CN112410418A (zh) * 2020-11-23 2021-02-26 复旦大学附属中山医院 一种扩张型心肌病分子标志物
CN112899364B (zh) * 2021-04-14 2022-06-17 大理大学 一种检测lmna基因突变的引物探针组合物及其应用
CN113355332B (zh) * 2021-07-22 2022-09-06 青岛市妇女儿童医院 Heg1基因突变体及其应用
CN115873862A (zh) * 2022-11-24 2023-03-31 百世诺(北京)医疗科技有限公司 肥厚型心肌病变异基因myh7及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101134960A (zh) * 2007-08-02 2008-03-05 中国人民解放军第二军医大学 扩张型心肌病的lmna基因突变及其检测方法
CN102154509A (zh) * 2010-12-28 2011-08-17 深圳华大基因科技有限公司 用于检测clcn1基因突变的方法、试剂盒及特异性引物
CN103509867A (zh) * 2013-09-24 2014-01-15 复旦大学附属中山医院 一种筛查扩张型心肌病的试剂盒
CN105695606A (zh) * 2016-04-07 2016-06-22 昆明理工大学 用于非治疗目的的肥厚型心肌病相关致病基因突变的筛查方法
CN106191290A (zh) * 2016-08-10 2016-12-07 四川金域医学检验中心有限公司 一种扩张型心肌病遗传性易感基因筛查试剂盒
CN106868175A (zh) * 2017-03-28 2017-06-20 昆明理工大学 一种引物组合物及其应用

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101134960A (zh) * 2007-08-02 2008-03-05 中国人民解放军第二军医大学 扩张型心肌病的lmna基因突变及其检测方法
CN102154509A (zh) * 2010-12-28 2011-08-17 深圳华大基因科技有限公司 用于检测clcn1基因突变的方法、试剂盒及特异性引物
CN103509867A (zh) * 2013-09-24 2014-01-15 复旦大学附属中山医院 一种筛查扩张型心肌病的试剂盒
CN105695606A (zh) * 2016-04-07 2016-06-22 昆明理工大学 用于非治疗目的的肥厚型心肌病相关致病基因突变的筛查方法
CN106191290A (zh) * 2016-08-10 2016-12-07 四川金域医学检验中心有限公司 一种扩张型心肌病遗传性易感基因筛查试剂盒
CN106868175A (zh) * 2017-03-28 2017-06-20 昆明理工大学 一种引物组合物及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation;Kang Li等;《Int. J. Mol. Sci》;20151224;第17卷(第1期);1-12 *
Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics;Hyun-Young Park, MD;《Korean Circulation Journal》;20170531;第47卷(第3期);291-298 *
扩张型心肌病致病基因LMNA新突变E82K的发现及其功能的初步研究;王虎等;《中华心血管病杂志》;20051031;第33卷(第10期);875-879 *
扩张型心肌病致病基因的研究进展;梁华生;《国际心血管病杂志》;20160131;第43卷(第1期);22-24 *

Also Published As

Publication number Publication date
CN107475259A (zh) 2017-12-15

Similar Documents

Publication Publication Date Title
CN107475259B (zh) 汉族人群家族性扩张型心肌病的筛查试剂盒
CN105543408B (zh) 冠心病早期诊断标志物
CN103957705A (zh) 适用于预测对醋酸格拉替雷的临床反应的单核苷酸多态性
CN110904128A (zh) 一种编码tek基因突变体的核酸及其应用
CN113355332B (zh) Heg1基因突变体及其应用
Nozari et al. A novel splicing variant in FLNC gene responsible for a highly penetrant familial dilated cardiomyopathy in an extended Iranian family
CN113981065A (zh) 具有c.223dupG杂合错义的肥厚型心肌病致病基因MYBPC3及其应用
AU2016351311B9 (en) SCAP gene mutant and the application thereof
CN114107482A (zh) 肺动脉高压突变基因及其应用
CN107287317A (zh) Myh7‑a934v突变基因用于制备诊断肥厚型心肌病试剂盒的应用
Kim et al. Novel in-frame deletion mutation in FLCN gene in a Korean family with recurrent primary spontaneous pneumothorax
CN104073499B (zh) Tmc1基因突变体及其应用
CN104745592B (zh) Cyp4v2基因突变体及其应用
CN105567862B (zh) Cdk18在制备诊断冠心病产品中的用途
CN108588085A (zh) 恶性心律失常的筛查试剂盒、动物模型的建立方法及应用
CN114875148A (zh) 一种家族性多发性脂肪瘤检测试剂盒及引物组的应用
CN113897368A (zh) Ttn基因突变体及其应用
CN104774840B (zh) 基因突变体及其应用
JP4657757B2 (ja) 肺高血圧症発症関連遺伝子を用いた肺高血圧症の診断および治療
CN105200151B (zh) Tcf21基因作为疾病诊断标志物的用途
CN104372009B (zh) 梅尔克松‑罗森塔尔综合征新的致病基因及其编码蛋白质和应用
CN113265409B (zh) Timm21突变基因、检测其的引物、试剂盒和方法以及其用途
CN113265405B (zh) Samm50突变基因、检测其的引物、试剂盒和方法以及其用途
CN113881767B (zh) 可导致心肌肥厚的突变基因及其应用
Boschi et al. Study by next generation sequencing of sudden cardiac death (SCD)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20210421

Address after: 201500 3rd floor, building 1, 1438 jinliu Road, Tinglin Town, Jinshan District, Shanghai

Patentee after: Gongwei Fuyi (Shanghai) Biotechnology Co.,Ltd.

Address before: 200032 Shanghai city Xuhui District Fenglin Road No. 180

Patentee before: Zhongshan Hospital, Fudan University

TR01 Transfer of patent right
CP01 Change in the name or title of a patent holder

Address after: 201500, 3rd Floor, Building 1, No. 1438 Jinliu Road, Tinglin Town, Jinshan District, Shanghai

Patentee after: Fuyi Tianwen (Shanghai) Biotechnology Co.,Ltd.

Address before: 201500, 3rd Floor, Building 1, No. 1438 Jinliu Road, Tinglin Town, Jinshan District, Shanghai

Patentee before: Gongwei Fuyi (Shanghai) Biotechnology Co.,Ltd.

CP01 Change in the name or title of a patent holder